Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.392920740862144e-30,14.42587583719732,969.7414411445433,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.765430316367802e-27,0,0,71
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.79062527458007e-12,4.539016329839196,120.75941935927803,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'UCP1', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP3', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1E', 'UQCRQ']",8.218391433638306e-10,0,0,52
3,"GPCRs, Class A Rhodopsin-like WP455",1.35715324328942e-10,2.885236227198042,65.55389898623498,"['NPFFR2', 'GPR27', 'OXTR', 'NPFFR1', 'CHRM1', 'GPR68', 'GPR65', 'GPR22', 'NPY2R', 'HTR2B', 'GPR20', 'ADRA1D', 'MC4R', 'CYSLTR2', 'ADORA3', 'GPR171', 'C3AR1', 'CMKLR1', 'PTGDR', 'GPR39', 'GPR35', 'OR2H2', 'GPR37L1', 'AVPR1A', 'SSTR1', 'SSTR3', 'TRHR', 'CCKBR', 'ADORA2A', 'ADORA2B', 'OR7A5', 'APLNR', 'OR3A3', 'OR3A2', 'CX3CR1', 'GPR87', 'CXCR5', 'OPRL1', 'CXCR4', 'GPR83', 'ADRB1', 'ADRB2', 'MCHR1', 'HRH1', 'P2RY6', 'CNR2', 'OR2AG1', 'P2RY1', 'RHO', 'DRD2', 'DRD3', 'NTSR1', 'DRD5', 'CCR1', 'GPR17', 'GPR12', 'HTR1E', 'P2RY14', 'HTR1D', 'GPR52', 'HTR1B', 'GPR4', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'ACKR4', 'RGL4', 'OR7C1', 'GPR18', 'F2RL2']",2.6645442009915616e-08,0,0,74
4,TYROBP causal network in microglia WP3945,1.5844970736978832e-07,4.116827339964295,64.46057685524399,"['CD84', 'RBM47', 'ITGAM', 'PLEK', 'ITGB2', 'GIMAP2', 'CAPG', 'TCIRG1', 'SLC1A5', 'SAMSN1', 'ZFP36L2', 'C3', 'LYL1', 'ADAP2', 'RGS1', 'ITGAX', 'SPP1', 'CYTL1', 'NCKAP1L', 'IL13RA1', 'IL10RA', 'RNASE6', 'LHFPL2', 'TNFRSF1B', 'RUNX3', 'APBB1IP', 'TYROBP', 'BIN2', 'ELF4', 'HCLS1', 'TMEM106A', 'C1QC']",2.333171941020133e-05,0,0,32
5,Spinal Cord Injury WP2431,2.500773635016972e-07,2.8195440573770494,42.86128633677752,"['CDKN1B', 'XYLT1', 'AQP4', 'CXCL1', 'AQP1', 'TNFSF13B', 'LGALS3', 'GJA1', 'ZFP36', 'PRB1', 'MYC', 'SOX9', 'ROS1', 'IL1R1', 'MIF', 'PDYN', 'RHOC', 'VCAN', 'IL1B', 'LTB', 'TLR4', 'C1QB', 'PLA2G5', 'PTGS2', 'AIF1', 'RTN4', 'EGFR', 'ACAN', 'CHST11', 'PTPRZ1', 'CCL2', 'SLIT3', 'MAPK3', 'NGFR', 'EGR1', 'GADD45A', 'BDNF', 'TNFSF13', 'LILRB2', 'GFAP', 'SELP', 'NR4A1', 'FCGR2A', 'LEP', 'APEX1', 'CDK2', 'CDK1', 'CSPG4', 'VIM']",2.9459113420499928e-05,0,0,49
6,Microglia Pathogen Phagocytosis Pathway WP3937,5.633042372767858e-07,5.13962840417409,73.95640522175694,"['C1QB', 'VAV3', 'LYN', 'C1QA', 'ITGAM', 'FCER1G', 'NCF1', 'SYK', 'NCF4', 'ITGB2', 'CYBB', 'TREM2', 'CYBA', 'PIK3R6', 'VAV1', 'HCK', 'TYROBP', 'PLCG2', 'RAC3', 'NCKAP1L', 'PTPN6', 'FCGR1A', 'SIGLEC7', 'C1QC']",5.529769929267114e-05,0,0,24
7,Oxidative phosphorylation WP623,1.7259344099847703e-06,3.91209083356411,51.91243591361543,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",0.00014522505249728996,0,0,28
8,Complement system WP2806,3.1739305480056417e-06,2.9104907863528555,36.84838448948064,"['FCN1', 'FKBP2', 'SELPLG', 'CFH', 'C1R', 'CFI', 'C5AR1', 'ITGB2', 'ICAM2', 'F13A1', 'C4BPA', 'PLG', 'TXN', 'LRP2', 'THBS1', 'C3', 'FCGR3A', 'C6', 'RPS19', 'C7', 'C9', 'C3AR1', 'ITGAX', 'SPP1', 'CD59', 'VSIG4', 'PRNP', 'CR1', 'CD93', 'F12', 'F11', 'APOA1', 'SELE', 'SELP', 'ALB', 'MASP2', 'PTX3', 'TLR2']",0.00023368063659691537,0,0,38
9,Selenium Micronutrient Network WP15,1.7480803451792844e-05,2.802245470783363,30.696938030621304,"['SERPINA3', 'PLG', 'TXN', 'SELENOK', 'PTGS2', 'SELENOH', 'PRDX3', 'PRDX5', 'KYNU', 'RFK', 'ALOX5', 'PNPO', 'CCL2', 'SEPHS2', 'XDH', 'GGT2', 'ABCA1', 'GPX4', 'GPX3', 'DIO3', 'APOA1', 'F2', 'KMO', 'SOD3', 'NFKB2', 'F7', 'SELENOM', 'IL1B', 'SELENOP', 'ALOX5AP', 'ALB', 'SELENOW', 'SELENOV', 'SAA2']",0.0010613739155117537,0,0,34
10,Mitochondrial CIV Assembly WP4922,1.8019930653849806e-05,4.689628876461617,51.22965663716647,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",0.0010613739155117537,0,0,19
11,Nonalcoholic fatty liver disease WP4396,2.520465497670175e-05,2.1084072418089863,22.324831831717407,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'PRKAG2', 'COX6A1', 'COX7C', 'CASP7', 'LEPR', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'IL1B', 'PPARA', 'CEBPA', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CCL2', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'VCAM1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'UQCRQ', 'LEP', 'CYCS', 'BAX']",0.0013495947073888482,0,0,55
12,Vitamin D Receptor Pathway WP2877,3.372865888842921e-05,2.0946427412651376,21.568877042094485,"['CDKN1A', 'STEAP4', 'ITGAM', 'CDKN1B', 'HILPDA', 'TNFAIP3', 'CLDN2', 'THBD', 'SULT1C2', 'CASP5', 'MYC', 'TIMP2', 'SOSTDC1', 'CA9', 'LGALS9', 'EPHB4', 'IGFBP5', 'CEACAM1', 'S100A6', 'IRF8', 'S100A4', 'S100A9', 'S100A8', 'COLEC11', 'CEBPA', 'COL13A1', 'LRP5', 'TNFRSF11B', 'ADRB2', 'CYP3A4', 'CYP3A5', 'FOXO1', 'IL1RL1', 'CLMN', 'ALOX5', 'CREG2', 'BTLA', 'SPP1', 'CD14', 'HLA-DQA1', 'CDKN2D', 'LRRC25', 'GADD45A', 'VDR', 'CDKN2A', 'MX2', 'NFATC2', 'G0S2', 'KLF4', 'CYP24A1', 'TRPV6', 'BCL6', 'CDK2', 'PNOC']",0.001655515007107067,0,0,54
13,Complement and Coagulation Cascades WP558,3.664877612248022e-05,3.2111026228673287,32.79862131543094,"['C1QB', 'C1QA', 'CPB2', 'SERPINA1', 'CFH', 'C1R', 'C5AR1', 'CFI', 'PLG', 'TFPI', 'C3', 'THBD', 'C6', 'C7', 'C9', 'C3AR1', 'CR1', 'VWF', 'SERPIND1', 'F12', 'SERPINF2', 'F2', 'F5', 'F7', 'MASP2', 'C1QC']",0.0016604714720108347,0,0,26
14,Nuclear Receptors Meta-Pathway WP2882,5.512325671277408e-05,1.6974837081628316,16.64542143934276,"['SERPINA1', 'CDKN1B', 'SRXN1', 'TNFAIP3', 'SLC2A2', 'SLC2A3', 'SLC7A11', 'SLC2A5', 'THBD', 'RGS2', 'ZIC2', 'MYC', 'FTH1', 'SLCO2B1', 'ENC1', 'PDK4', 'CYP1B1', 'SLC39A5', 'SLC39A7', 'GGT2', 'SLC39A3', 'SRGN', 'ABCC3', 'HSP90AA1', 'SERPINB2', 'ABCC2', 'SLC2A10', 'GPX3', 'HGF', 'SLC2A12', 'MYOF', 'CYP4A11', 'SLC39A11', 'AIP', 'APOA1', 'SLC39A12', 'CES4A', 'TGFBR2', 'TGFBR3', 'KAT2B', 'CYP2A6', 'CDC37', 'IL1B', 'B3GNT5', 'ANGPTL4', 'PPARA', 'EPHA2', 'FKBP5', 'FTL', 'NR1I3', 'AMIGO2', 'SLC5A11', 'SLC5A12', 'TXN', 'SLC5A2', 'ABCB11', 'PTGS2', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'EGFR', 'FOXO1', 'CYP3A7', 'PRRG4', 'FGD4', 'SLCO1B1', 'DNAJB1', 'HMOX1', 'CCL2', 'STOM', 'HES1', 'IP6K3', 'CBR3', 'EGR1', 'JUN', 'GADD45B', 'SLC10A1', 'CAVIN2', 'VDR', 'PLK2', 'SOD3', 'NFKB2', 'SLC2A9', 'BHLHE40', 'ALOX5AP', 'CDK1', 'BAX', 'SPRY1', 'HSPA1A']",0.002319114157415995,0,0,91
15,Hematopoietic Stem Cell Differentiation WP2849,0.00015512286482007604,3.075445292620865,26.975632009357682,"['NOTCH1', 'CSF1', 'LEF1', 'RHOH', 'CXCR4', 'NFATC2', 'IKZF1', 'GATA2', 'GATA1', 'VAV1', 'ABO', 'FLI1', 'RUNX1', 'LYL1', 'MUC1', 'TPO', 'IL5', 'TRIM29', 'IL1B', 'PIM1', 'FOSB', 'NCKAP1L', 'CD34']",0.006091157825268319,0,0,23
16,Apoptosis Modulation and Signaling WP1772,0.0003781228971882551,2.204380986697895,17.371164290087812,"['BCL2A1', 'TNFRSF11B', 'CASP7', 'BCL2L10', 'CAPNS1', 'CASP6', 'CASP10', 'BAG3', 'CASP4', 'CASP1', 'TNFSF10', 'PMAIP1', 'FADD', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'IL1R1', 'BIK', 'CDKN2A', 'BAD', 'IL1R2', 'TNFRSF10C', 'TNFRSF10B', 'TNFRSF10A', 'TNFRSF1B', 'PTPN13', 'TNFRSF10D', 'NFKBIA', 'TOLLIP', 'CYCS', 'BAX', 'PRKD1', 'BCL2L2', 'HSPA1A']",0.01391964915274264,0,0,35
17,Glycolysis and Gluconeogenesis WP534,0.0004347012261849245,3.0547382950128945,23.64627581612542,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A2', 'SLC2A3', 'ENO2', 'SLC2A5', 'HK2', 'GCK', 'LDHC', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'PFKM', 'GAPDH']",0.015061118954289443,0,0,20
18,Role of Osx and miRNAs in tooth development WP3971,0.0008386392104906904,8.539416983523447,60.490923988914496,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'ALPL', 'SP7', 'KLF4', 'BMP7', 'DKK1']",0.027442138609945366,0,0,8
19,Macrophage markers WP4146,0.0009816483571451146,11.206031424227065,77.61608222180693,"['CD86', 'CD74', 'CD163', 'CD83', 'CD14', 'LYZ', 'CD68']",0.030431099071498553,0,0,7
20,White fat cell differentiation WP4149,0.0010447195371796432,3.43412174417761,23.57183505578502,"['CEBPA', 'CEBPB', 'TCF7L1', 'EGR2', 'CEBPD', 'EBF1', 'RORA', 'NR2F2', 'GATA2', 'KLF4', 'KLF15', 'FOXO1', 'MECOM', 'DDIT3', 'ZNF423']",0.03076699036994049,0,0,15
21,Peptide GPCRs WP24,0.0013338851512738421,2.5200421557582584,16.681820817068566,"['CX3CR1', 'CCR1', 'OXTR', 'NPY2R', 'C5AR1', 'TACR2', 'CXCR5', 'OPRL1', 'CXCR4', 'SSTR1', 'AVPR1A', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'CCKBR', 'C3AR1', 'GNRHR', 'TAC4', 'NTSR1']",0.037412302576204426,0,0,22
22,Glucocorticoid Receptor Pathway WP2880,0.001606086018973236,2.254482136835078,14.505236850913024,"['NR1I3', 'AMIGO2', 'TNFAIP3', 'PTGS2', 'PRRG4', 'THBD', 'FGD4', 'RGS2', 'ZIC2', 'ENC1', 'CCL2', 'STOM', 'SRGN', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'CAVIN2', 'PLK2', 'NFKB2', 'TGFBR3', 'B3GNT5', 'ALOX5AP', 'BHLHE40', 'SPRY1', 'ANGPTL4']",0.04299930296251073,0,0,26
23,Blood Clotting Cascade WP272,0.0020968805905621267,4.575558856563168,28.218864596461554,"['F7', 'F8A1', 'SERPINB2', 'VWF', 'F12', 'SERPINF2', 'F11', 'PLG', 'F2', 'F5']",0.0536983768626562,0,0,10
24,Heart Development WP1591,0.002472765523202764,3.0043803961401725,18.03354729808695,"['TBX1', 'FOXC1', 'NOTCH1', 'VEGFC', 'NFATC2', 'NFATC1', 'TBX2', 'NFATC4', 'FGF8', 'HEY1', 'ERBB3', 'HEY2', 'BHLHE40', 'SMYD1', 'FGF10']",0.060685787215267836,0,0,15
25,Imatinib and Chronic Myeloid Leukemia WP3640,0.0026107430863282744,3.9150177574835108,23.286996953488973,"['PDGFRA', 'CSF1R', 'LYL1', 'SPRED2', 'CDKN1B', 'FLT1', 'GADD45A', 'MYC', 'PIM1', 'PIM2', 'ABCG2']",0.061509107113894144,0,0,11
26,Drug Induction of Bile Acid Pathway WP2289,0.0029351044026535633,4.803498985801217,28.009261451800374,"['ABCC3', 'SLCO1B1', 'ABCC2', 'VDR', 'SLC10A1', 'NR1I3', 'SLC51A', 'CYP3A4', 'ABCB11']",0.06402875900603514,0,0,9
27,Platelet-mediated interactions with vascular and circulating cells WP4462,0.0029351044026535633,4.803498985801217,28.009261451800374,"['SELP', 'VCAM1', 'SELPLG', 'IL1B', 'CCL2', 'TLR7', 'SELE', 'TLR4', 'TLR2']",0.06402875900603514,0,0,9
28,Gastric acid production WP2596,0.0032204556091662844,inf,inf,"['GRP', 'CCK', 'VIP', 'MUC6']",0.06774458406424791,0,0,4
29,Mitochondrial complex I assembly model OXPHOS system WP4324,0.003396137453716551,2.3217718455116287,13.19954351213345,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.06819036019610333,0,0,21
30,"GPCRs, Other WP117",0.0034836384171737225,2.084899414311179,11.799859366564784,"['GPR88', 'ADRA1D', 'GPR83', 'ADRB2', 'GPR84', 'ADGRE2', 'GPR132', 'PROKR2', 'ADORA3', 'ADGRE3', 'HRH4', 'GNRHR', 'DRD3', 'NTSR1', 'GPR135', 'GPR17', 'ADGRV1', 'GPR55', 'GPR162', 'CCKBR', 'SMO', 'ADORA2A', 'OR10A2', 'LGR6', 'OR3A3', 'GPR18']",0.06819036019610333,0,0,26
31,Thyroxine (Thyroid Hormone) Production WP1981,0.003688131343626601,16.00177304964539,89.65209951288382,"['TPO', 'TG', 'TRH', 'CGA', 'TSHR']",0.06819036019610333,0,0,5
32,Vitamin B12 metabolism WP1533,0.003704739433404595,2.5945484901277585,14.524651784496903,"['ABCA1', 'SERPINA3', 'CUBN', 'APOA1', 'PLG', 'LRP2', 'F2', 'SOD3', 'NFKB2', 'F7', 'TCN2', 'TCN1', 'IL1B', 'ALB', 'CCL2', 'SAA2', 'APOE']",0.06819036019610333,0,0,17
33,Proximal tubule transport WP4917,0.0044965194559647755,2.2442014242115973,12.128678057934014,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'SLC2A2', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC4A4', 'AQP1', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0D2', 'ATP6V0C', 'ATP6V1D', 'ABCG2', 'ATP6V1B1', 'ATP6V1F']",0.08025605938070463,0,0,21
34,Sleep regulation WP3591,0.005164510976873591,2.803376491495303,14.762426029040723,"['CHRNB2', 'OXTR', 'AHCY', 'NPY2R', 'HCRTR2', 'HCRTR1', 'STAR', 'ADORA2A', 'CRH', 'UTS2', 'GHRL', 'DRD2', 'DRD3', 'PTGDR']",0.08946755780525134,0,0,14
35,Pre-implantation embryo WP3527,0.006971391904846232,2.3685600035348178,11.762127751554798,"['EGR1', 'DLX2', 'TCF7L1', 'FOXD1', 'HMGA1', 'ATP1A1', 'GATA2', 'KLF4', 'AQP3', 'ZFP36L2', 'TBX3', 'ZFP36', 'ARGFX', 'CDH1', 'DDIT3', 'SIX3', 'FOSB']",0.11731856662726946,0,0,17
36,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.00889980526018449,3.6020537525354968,17.00791043660656,"['TLR1', 'JUN', 'TIFA', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.14561070272912957,0,0,9
37,COVID-19 adverse outcome pathway WP4891,0.010365656043242896,8.000253292806484,36.55521528804913,"['IL7', 'IL1B', 'CCL3', 'CCL2', 'AGT']",0.15558366745530564,0,0,5
38,Allograft Rejection WP2328,0.01063351628537926,1.9402303468595152,8.815910681064683,"['CD86', 'C1QB', 'PDGFRA', 'C1QA', 'HLA-DRB5', 'CD80', 'CXCR5', 'CXCL13', 'HLA-E', 'C3', 'CASP7', 'C6', 'IL5', 'C7', 'GNLY', 'IL1B', 'C9', 'HLA-DRA', 'VIM', 'HLA-DOA', 'HLA-DQA1', 'HLA-DPA1', 'C1QC']",0.15558366745530564,0,0,23
39,Computational Model of Aerobic Glycolysis WP4629,0.010830102488399882,4.481348200709579,20.280008562976217,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.15558366745530564,0,0,7
40,EDA signaling in hair follicle development WP3930,0.010830102488399882,4.481348200709579,20.280008562976217,"['EDA', 'PTCH1', 'SOSTDC1', 'LTB', 'GLI1', 'DKK1', 'RELB']",0.15558366745530564,0,0,7
41,Transcriptional cascade regulating adipogenesis WP4211,0.010830102488399882,4.481348200709579,20.280008562976217,"['CEBPA', 'CEBPB', 'EGR2', 'CEBPD', 'DDIT3', 'GATA2', 'KLF15']",0.15558366745530564,0,0,7
42,Lung fibrosis WP3624,0.011585530955394207,2.1362134688691232,9.523235993144953,"['EDN1', 'CEBPB', 'SERPINA1', 'HGF', 'MMP2', 'FAM13A', 'FGF2', 'BMP7', 'FGF7', 'CYSLTR2', 'IL5', 'TERT', 'IL1B', 'CCL3', 'SPP1', 'HMOX1', 'CCL2', 'PTX3']",0.16247327935064731,0,0,18
43,Mitochondrial complex III assembly WP4921,0.012863349732491407,3.6585913452833605,15.927213209469684,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.17529717824827615,0,0,8
44,"COVID-19, thrombosis and anticoagulation WP4927",0.013522745243520505,inf,inf,"['F13A1', 'PLG', 'F2']",0.17529717824827615,0,0,3
45,Complement Activation WP545,0.014083704879965018,3.2015720081135903,13.647458919880577,"['C1QB', 'C3', 'C1QA', 'C6', 'C7', 'C1R', 'C9', 'MASP2', 'C1QC']",0.17529717824827615,0,0,9
46,NRF2 pathway WP2884,0.014316824763555568,1.583808205532881,6.725356263599156,"['SERPINA1', 'SRXN1', 'SLC5A11', 'SLC2A2', 'SLC5A12', 'SLC2A3', 'TXN', 'SLC7A11', 'SLC5A2', 'SLC2A5', 'SLC5A3', 'SLC5A4', 'DNAJB1', 'FTH1', 'SLC39A5', 'HMOX1', 'SLC39A7', 'GGT2', 'SLC39A3', 'CBR3', 'ABCC3', 'EGR1', 'HSP90AA1', 'ABCC2', 'GPX3', 'SLC2A10', 'HGF', 'CYP4A11', 'SLC2A12', 'SLC39A11', 'SLC39A12', 'SOD3', 'CES4A', 'TGFBR2', 'SLC2A9', 'CYP2A6', 'FTL', 'EPHA2', 'HSPA1A']",0.17529717824827615,0,0,39
47,Monoamine GPCRs WP58,0.014481009248993955,2.449193789190803,10.372132891577794,"['CHRM1', 'HTR1E', 'HTR1D', 'HTR2B', 'HTR1B', 'ADRB1', 'ADRA1D', 'ADRB2', 'HTR5A', 'HRH1', 'DRD2', 'DRD3', 'DRD5']",0.17529717824827615,0,0,13
48,Toll-like Receptor Signaling related to MyD88 WP3858,0.014481009248993955,2.449193789190803,10.372132891577794,"['TICAM2', 'RELB', 'NFKB2', 'TLR1', 'TOLLIP', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2']",0.17529717824827615,0,0,13
49,Differentiation of white and brown adipocyte WP2895,0.014706366868796148,2.910797039632951,12.282034636257345,"['PLAC8', 'CEBPA', 'CEBPB', 'LEP', 'ZIC1', 'PRDM16', 'EBF3', 'SLC7A10', 'ZNF423', 'BMP7']",0.17529717824827615,0,0,10
50,Folate Metabolism WP176,0.014880914961653325,2.059756761662734,8.666788601888742,"['ABCA1', 'SERPINA3', 'AHCY', 'CSF1', 'GPX4', 'GPX3', 'APOA1', 'PLG', 'F2', 'SOD3', 'NFKB2', 'F7', 'RFK', 'IL1B', 'ALB', 'CCL2', 'SAA2', 'FOLR2']",0.17529717824827615,0,0,18
51,Myometrial relaxation and contraction pathways WP289,0.016050882352999153,1.5063178073891446,6.224092309629081,"['RYR1', 'RGS18', 'OXTR', 'RAMP2', 'RGS14', 'YWHAB', 'LPAR1', 'ADCY4', 'ITPR2', 'ATP2A2', 'RXFP2', 'ETS2', 'RYR3', 'ACTG1', 'RGS4', 'CNN2', 'GJA1', 'RGS2', 'GNG3', 'RGS1', 'PLCG2', 'RGS20', 'SFN', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP2', 'GNG12', 'GNG11', 'ACTA2', 'CREB3', 'ACTA1', 'ADCY9', 'ACTC1', 'PRKAR1A', 'IL1B', 'CRH', 'RGS10', 'CALM3', 'PRKD1', 'CALM1', 'CALM2']",0.1853719550179706,0,0,46
52,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.016553173862342674,1.5181178256958714,6.22607054974706,"['TPH1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'SLC1A3', 'ATP1A3', 'AQP4', 'RORA', 'GATA2', 'FOXM1', 'NEUROD1', 'GJA1', 'HES1', 'PKNOX1', 'SCN3B', 'TAC1', 'YWHAG', 'HES5', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'BDNF', 'SSTR1', 'RUNX3', 'GCK', 'NFKB2', 'ADCYAP1', 'PRKAR1A', 'SST', 'PAH', 'IL1B', 'BHLHE40', 'CHRFAM7A', 'AVP', 'ALDOA', 'GAPDH', 'SCN4B', 'SLC25A4']",0.18749652701768912,0,0,44
53,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.02872011421710864,2.347894469812278,8.335395297135003,"['RAB3B', 'FGD4', 'EGR2', 'RAB3A', 'RAB25', 'SH3TC2', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'RAB11A']",0.2962010367945224,0,0,11
54,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.02872011421710864,2.347894469812278,8.335395297135003,"['ABCA1', 'ABCC3', 'CYP26A1', 'ABCC2', 'CYP24A1', 'VDR', 'NR1I3', 'CYP4A11', 'CYP3A4', 'ABCB11', 'PPARA']",0.2962010367945224,0,0,11
55,Purinergic signaling WP4900,0.02872011421710864,2.347894469812278,8.335395297135003,"['P2RY8', 'P2RX7', 'GNAZ', 'P2RY6', 'ADORA2A', 'GNAT3', 'ADORA2B', 'ADORA3', 'P2RY14', 'P2RX1', 'P2RY1']",0.2962010367945224,0,0,11
56,Cells and molecules involved in local acute inflammatory response  WP4493,0.02981003680484855,3.20045615813482,11.242914879800358,"['SELP', 'C3', 'VCAM1', 'SELPLG', 'C6', 'C7', 'ITGB2']",0.2962010367945224,0,0,7
57,Cytokines and Inflammatory Response WP530,0.02981003680484855,3.20045615813482,11.242914879800358,"['IL5', 'CSF1', 'IL15', 'IL7', 'IL1B', 'HLA-DRA', 'CXCL1']",0.2962010367945224,0,0,7
58,Nephrogenesis WP5052,0.02981003680484855,3.20045615813482,11.242914879800358,"['NOTCH2', 'MEIS1', 'FOXD1', 'FGF8', 'ALDH1A2', 'BMP7', 'PAX2']",0.2962010367945224,0,0,7
59,Constitutive Androstane Receptor Pathway WP2875,0.02981968679137455,2.462591935074816,8.650067119682552,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'NR1I3', 'CYP4A11', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.2962010367945224,0,0,10
60,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.03067616849654646,2.8451204055766794,9.91316538895443,"['TCF7L1', 'VCAM1', 'NOTCH1', 'EPAS1', 'LEF1', 'TNC', 'CXCR4', 'CYTIP']",0.2962010367945224,0,0,8
61,Cancer immunotherapy by PD-1 blockade WP4585,0.03067616849654646,2.8451204055766794,9.91316538895443,"['ZAP70', 'JUN', 'CD8B', 'NFATC2', 'NFATC1', 'PDCD1LG2', 'BATF', 'NFATC4']",0.2962010367945224,0,0,8
62,Cellular Proteostasis WP4918,0.03172908943228252,6.398581919473284,22.07844365835067,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.3014263496066839,0,0,4
63,IL-18 signaling pathway WP4754,0.033284799980556536,1.3275862068965518,4.517317105686412,"['SPON1', 'CD83', 'NCF1', 'HSPB1', 'TNFAIP3', 'RND2', 'EPS8', 'PPP1R13L', 'TMSB4X', 'FAM186B', 'STMN1', 'NPPA', 'TGM2', 'TICAM2', 'USP5', 'IMP3', 'MMP2', 'NDUFC1', 'BPGM', 'ACTA2', 'ARL4D', 'ACTA1', 'MMP14', 'IL1B', 'LTB', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'SDC4', 'TSHZ1', 'MEPCE', 'COX17', 'TNFRSF11B', 'PTGS2', 'GATA1', 'ACACB', 'FUT1', 'CCNB2', 'SOCS3', 'PTPRZ1', 'SPP1', 'CCL3', 'HMOX1', 'CCL2', 'FADD', 'MAPK3', 'SLC12A3', 'JUN', 'BAD', 'NFATC4', 'NFKB2', 'NFKBIA', 'NR4A1', 'COL1A2', 'NACA', 'TNIP3', 'CYCS', 'BAX', 'PTX3', 'PTPN7', 'NFKBIE', 'IL18R1', 'CDK5R2', 'SNTB1', 'ITM2C']",0.31118646331028255,0,0,67
64,Oxidation by Cytochrome P450 WP43,0.03419794967182547,1.8978917957835915,6.4065037846692485,"['CYP2J2', 'CYP4A11', 'CYP3A43', 'CYP3A4', 'CYP2C19', 'CYP4F11', 'CYP3A5', 'CYP2C18', 'CYP3A7', 'CYP39A1', 'CYP26A1', 'CYP26B1', 'CYP2A6', 'CYP24A1', 'CYP11A1', 'CYP1B1']",0.31472800557351877,0,0,16
65,Exercise-induced Circadian Regulation WP410,0.03885561751857423,1.8148882113821139,5.894580172306146,"['IDI1', 'HSPA8', 'CEBPB', 'BTG1', 'G0S2', 'GFRA1', 'QKI', 'HERPUD1', 'PER2', 'DNAJA1', 'CLDN5', 'SUMO1', 'TUBB3', 'STBD1', 'UCP3', 'SUMO3', 'EIF4G2']",0.34166929391362905,0,0,17
66,Fatty Acid Omega Oxidation WP206,0.04032632347420966,3.9994934143870315,12.84137682109299,"['CYP2A6', 'ADH1B', 'CYP4A11', 'ALDH1A1', 'CYP3A4']",0.34166929391362905,0,0,5
67,Irinotecan pathway WP229,0.04032632347420966,3.9994934143870315,12.84137682109299,"['SLCO1B1', 'ABCC2', 'CYP3A4', 'CYP3A5', 'ABCG2']",0.34166929391362905,0,0,5
68,Nucleotide GPCRs WP80,0.04032632347420966,3.9994934143870315,12.84137682109299,"['P2RY6', 'ADORA2A', 'ADORA2B', 'ADORA3', 'P2RY1']",0.34166929391362905,0,0,5
69,Pregnane X receptor pathway WP2876,0.040475601034349745,2.28651135828412,7.332969810615747,"['ABCC3', 'SLCO1B1', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.34166929391362905,0,0,10
70,Regulation of toll-like receptor signaling pathway WP1449,0.040605858359854044,1.460857088381382,4.680356651730628,"['CD86', 'CD80', 'PELI3', 'PELI2', 'LY96', 'TNFAIP3', 'PIK3R5', 'TIFA', 'CCL3', 'SPP1', 'MAP3K8', 'FADD', 'CD14', 'MAPK3', 'JUN', 'TICAM2', 'CISH', 'SYK', 'CD180', 'IRAK3', 'SMAD6', 'NFKB2', 'NFKBIA', 'TLR1', 'TOLLIP', 'IL1B', 'BTK', 'IRF7', 'TLR9', 'TLR7', 'PTPN6', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2']",0.34166929391362905,0,0,36
71,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.04383736984591274,3.199898657208006,10.00694269797039,"['ZAP70', 'HLA-DRB5', 'CD8B', 'IGLL1', 'HLA-DRA', 'CD247']",0.3595366773182918,0,0,6
72,TP53 network WP1742,0.04395015410342447,2.560405576679341,8.000497125321097,"['CDKN1A', 'SUMO1', 'CDKN2A', 'GADD45A', 'MYC', 'TNFSF10', 'PMAIP1', 'BAX']",0.3595366773182918,0,0,8
73,Cori Cycle WP1946,0.044638405723342156,2.8001773948302078,8.70620144079325,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'SLC2A2', 'ALDOA', 'GAPDH']",0.36016467083628123,0,0,7
74,Aryl Hydrocarbon Receptor Pathway WP2873,0.04639465435302566,2.0219821311716237,6.208639763839275,"['HSP90AA1', 'JUN', 'CDKN1B', 'SERPINB2', 'CDC37', 'IL1B', 'MYOF', 'AIP', 'CYP1B1', 'BAX', 'HES1', 'EGFR']",0.36927637045854206,0,0,12
75,Eicosanoid Synthesis WP167,0.0570637625960368,2.215770791075051,6.3450502039583565,"['PTGES2', 'ALOX5', 'ALOX15', 'ALOX5AP', 'TBXAS1', 'PLA2G5', 'LTC4S', 'PTGS2', 'GGT2']",0.4365007294683854,0,0,9
76,Inflammatory Response Pathway WP453,0.0570637625960368,2.215770791075051,6.3450502039583565,"['CD86', 'ZAP70', 'IL4R', 'COL1A2', 'IL5', 'LAMB2', 'CD80', 'TNFRSF1B', 'THBS1']",0.4365007294683854,0,0,9
77,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.0570637625960368,2.215770791075051,6.3450502039583565,"['GSK3A', 'BCL2L10', 'BCL2A1', 'ITGB4', 'MYC', 'BAX', 'ITGA6', 'BCL2L14', 'BCL2L2']",0.4365007294683854,0,0,9
78,Codeine and Morphine Metabolism WP1604,0.06021370772248823,4.26538364142821,11.985110616239034,"['ABCC3', 'SLCO1B1', 'ABCC2', 'CYP3A4']",0.44543254288569295,0,0,4
79,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.06021370772248823,4.26538364142821,11.985110616239034,"['CD86', 'IL5', 'CD80', 'VIP']",0.44543254288569295,0,0,4
80,Kynurenine Pathway and links to Cellular Senescence WP5044,0.06050017560416882,2.3274570803087915,6.52877082962397,"['CDKN1A', 'IL1R2', 'HAAO', 'KYNU', 'KMO', 'TLR4', 'FOXO1', 'ACMSD']",0.44543254288569295,0,0,8
81,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.06361120367124365,1.9561136478944698,5.389025938346643,"['IFIH1', 'OAS1', 'OAS2', 'OAS3', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR4', 'TLR3', 'TLR2']",0.4478660666123796,0,0,11
82,Gene regulatory network modelling somitogenesis  WP2854,0.06513390990682132,3.199341438703141,8.738393187768983,"['LFNG', 'NOTCH1', 'FGF8', 'HES1', 'TBX6']",0.4478660666123796,0,0,5
83,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.06513390990682132,3.199341438703141,8.738393187768983,"['SOCS3', 'CDH1', 'MYC', 'CHI3L1', 'BAX']",0.4478660666123796,0,0,5
84,Tamoxifen metabolism WP691,0.06513390990682132,3.199341438703141,8.738393187768983,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.4478660666123796,0,0,5
85,Farnesoid X receptor pathway WP2879,0.06539300802829312,2.742553114481161,7.479874638788336,"['SLC10A1', 'SLCO2B1', 'CYP3A4', 'ABCB11', 'IP6K3', 'FKBP5']",0.4478660666123796,0,0,6
86,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.06539300802829312,2.742553114481161,7.479874638788336,"['ABCA1', 'ANXA2', 'LIPG', 'LPL', 'APOA1', 'APOE']",0.4478660666123796,0,0,6
87,Vitamin A and carotenoid metabolism WP716,0.07418981211469684,1.7237877633917238,4.483793378075133,"['LPL', 'RLBP1', 'RPE65', 'CYP26A1', 'ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'ALDH1A2', 'ALDH1A1', 'LRAT', 'BCO1']",0.5022735555811085,0,0,14
88,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.08046566952869363,2.1333333333333333,5.375839255470831,"['CD86', 'LDHA', 'CYP24A1', 'VDR', 'CD80', 'MYC', 'HLA-DRA', 'SLC2A3']",0.5378131598427572,0,0,8
89,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.08126548595247095,1.7338832487309646,4.35210569757759,"['NDUFA13', 'HSP90AA1', 'CARD6', 'ERBIN', 'NLRC4', 'NOD2', 'NFKBIA', 'CASP7', 'ACAP1', 'CASP5', 'IL1B', 'CASP1', 'AAMP']",0.5378131598427572,0,0,13
90,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.0869570174209638,1.882561799764288,4.597858499339839,"['EGLN2', 'VCAM1', 'BCL2A1', 'MMP2', 'IL1B', 'PTGS2', 'SELE', 'BCL2L2', 'RELB', 'NFKB2']",0.5690853695660854,0,0,10
91,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.0915216245095949,4.797721518987342,11.472215747456557,"['MAS1', 'REN', 'AGT']",0.5895138028050247,0,0,3
92,Hedgehog Signaling Pathway Netpath WP47,0.09208025442794954,2.3995439574360273,5.7231396987634655,"['SMO', 'PTCH1', 'SUFU', 'GLI1', 'GLI3', 'GLI2']",0.5895138028050247,0,0,6
93,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.09663408659575055,2.665906788247214,6.229754262593044,"['HSD11B1', 'HSD11B2', 'STAR', 'CYP11A1', 'HSD3B1']",0.5901450284229811,0,0,5
94,Glycolysis in senescence WP5049,0.09663408659575055,2.665906788247214,6.229754262593044,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.5901450284229811,0,0,5
95,Oxidative Damage WP3941,0.09764857272606896,1.6643959390862944,3.8720178208757687,"['C1QB', 'C1QA', 'CDKN1A', 'CDKN1B', 'C1R', 'BAD', 'GADD45A', 'C5AR1', 'TNFRSF1B', 'C3AR1', 'CYCS', 'NFKBIE', 'C1QC']",0.5901450284229811,0,0,13
96,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.09783454162861828,1.7602232369355657,4.091599446373422,"['ITGAM', 'TICAM2', 'TYROBP', 'SYK', 'ITGB2', 'LY96', 'CCL2', 'PLG', 'CD14', 'TLR4', 'TLR3']",0.5901450284229811,0,0,11
97,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.09783454162861828,1.7602232369355657,4.091599446373422,"['PDGFRA', 'EDA', 'SMO', 'CDH1', 'MYC', 'PTCH1', 'GJB6', 'LEF1', 'LRP5', 'GLI1', 'GLI2']",0.5901450284229811,0,0,11
98,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.09819051406698158,3.1987845024056725,7.423885150102983,"['APOE', 'TLR4', 'NFKB2', 'TLR2']",0.5901450284229811,0,0,4
99,Adipogenesis WP236,0.09985278803438746,1.338094161715319,3.083046955846008,"['CEBPA', 'CDKN1A', 'CEBPB', 'CEBPD', 'EPAS1', 'UCP1', 'LPL', 'RORA', 'GATA2', 'FOXO1', 'SOCS3', 'CYP26B1', 'NDN', 'GDF10', 'WWTR1', 'EGR2', 'GADD45B', 'GADD45A', 'EBF1', 'HMGA1', 'LIFR', 'MIF', 'PRLR', 'KLF15', 'AGT', 'SFRP4', 'CYP26A1', 'DDIT3', 'LEP', 'ID3', 'PLIN2', 'PPARA', 'LPIN3']",0.5940736581035779,0,0,33
100,Globo Sphingolipid Metabolism WP1424,0.10386845755024929,1.9690747782002536,4.459225837920058,"['B3GALNT1', 'ST6GAL1', 'ST6GAL2', 'B3GALT5', 'FUT2', 'A4GALT', 'FUT1', 'ABO']",0.5997894264421257,0,0,8
101,IL1 and megakaryocytes in obesity WP2865,0.10386845755024929,1.9690747782002536,4.459225837920058,"['TLR1', 'IL1R1', 'IL1B', 'TIMP2', 'CCL2', 'F2', 'S100A9', 'TLR2']",0.5997894264421257,0,0,8
102,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.10386845755024929,1.9690747782002536,4.459225837920058,"['CD86', 'IL4R', 'CD80', 'CCL2', 'TLR7', 'TLR4', 'NFKB2', 'TGFBR2']",0.5997894264421257,0,0,8
103,Genes controlling nephrogenesis WP4823,0.10741755122348584,1.6698035148880774,3.725384559534881,"['NOTCH2', 'FOXC1', 'EMX2', 'FGF8', 'FOXD1', 'EYA1', 'LAMB2', 'ITGA8', 'CXCR4', 'ETV4', 'GLI3', 'PAX2']",0.6091391044501633,0,0,12
104,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.10755597090461287,1.7778341364443317,3.9641148339850076,"['GGT5', 'CYSLTR2', 'HPGD', 'TRPA1', 'ALOX5', 'ALOX15', 'CYP4A11', 'TRPV1', 'LTC4S', 'PPARA']",0.6091391044501633,0,0,10
105,Canonical and non-canonical Notch signaling WP3845,0.11842365638358256,1.799885902636917,3.8400327714995264,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'LEF1', 'HES1', 'DLL3', 'DLK2']",0.6505724182572423,0,0,9
106,Breast cancer pathway WP4262,0.12177856410389565,1.2686829633640593,2.6712765956366202,"['SHC4', 'NOTCH2', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'SHC3', 'LEF1', 'LRP5', 'FGF2', 'EGFR', 'DLL3', 'FRAT1', 'FGF7', 'FRAT2', 'FGF8', 'HEY1', 'MYC', 'HEY2', 'HES1', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'GADD45B', 'GADD45A', 'CSNK2A3', 'FZD9', 'WNT16', 'NFKB2', 'FGF17', 'SFRP4', 'HEYL', 'RAD51', 'BAX', 'PGR', 'FGF10']",0.6505724182572423,0,0,40
107,Calcium Regulation in the Cardiac Cell WP536,0.12312831645218925,1.2629089979550103,2.6451985660715236,"['RYR1', 'RGS18', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'ADCY4', 'ITPR2', 'ATP2A2', 'ADRB1', 'ADRA1D', 'ADRB2', 'RYR3', 'RGS4', 'GJA1', 'RGS2', 'GNG3', 'PLN', 'RGS1', 'GJA4', 'RGS20', 'SFN', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG12', 'GNG11', 'GJD2', 'SLC8A3', 'GJB2', 'ADCY9', 'PRKAR1A', 'GJB3', 'GJB6', 'RGS10', 'CALM3', 'PRKD1', 'CASQ1', 'CALM1', 'CALM2']",0.6505724182572423,0,0,41
108,Prostaglandin Synthesis and Regulation WP98,0.12342113025135547,1.545097215291821,3.232579694485119,"['EDN1', 'HPGD', 'ANXA2', 'ANXA3', 'PTGS2', 'HSD11B1', 'HSD11B2', 'HPGDS', 'CYP11A1', 'TBXAS1', 'S100A6', 'SOX9', 'S100A10', 'PTGDR']",0.6505724182572423,0,0,14
109,Development and heterogeneity of the ILC family WP3893,0.12370816781801552,2.1327590575120343,4.457103802541967,"['IL5', 'NFIL3', 'IL15', 'IL7', 'IL1B', 'RORA']",0.6505724182572423,0,0,6
110,ERK Pathway in Huntington's Disease WP3853,0.12370816781801552,2.1327590575120343,4.457103802541967,"['CASP7', 'RPS6KA5', 'BDNF', 'ELK1', 'HRAS', 'EGFR']",0.6505724182572423,0,0,6
111,Major receptors targeted by epinephrine and norepinephrine WP4589,0.12370816781801552,2.1327590575120343,4.457103802541967,"['ADCY10', 'ADCY9', 'ADCY4', 'ADRB1', 'ADRA1D', 'ADRB2']",0.6505724182572423,0,0,6
112,Selective expression of chemokine receptors during T-cell polarization WP4494,0.12370816781801552,2.1327590575120343,4.457103802541967,"['CCR1', 'IL4R', 'IL5', 'CCL3', 'CXCR4', 'IL18R1']",0.6505724182572423,0,0,6
113,Endochondral Ossification with Skeletal Dysplasias WP4808,0.12918413487690072,1.4404574332909783,2.9479198907245268,"['HMGCS1', 'PTCH1', 'PTH1R', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'SPP1', 'ALPL', 'SOX9', 'CALM1', 'SLC38A2', 'CALM2', 'SOX5']",0.6632038790297115,0,0,18
114,Endochondral Ossification WP474,0.12918413487690072,1.4404574332909783,2.9479198907245268,"['HMGCS1', 'PTCH1', 'PTH1R', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'SPP1', 'ALPL', 'SOX9', 'CALM1', 'SLC38A2', 'CALM2', 'SOX5']",0.6632038790297115,0,0,18
115,Hippo-Merlin Signaling Dysregulation WP4541,0.13037509252408797,1.2972149316081212,2.642867422500891,"['CSF1R', 'FLT1', 'ITGAM', 'ITGB5', 'ITGB4', 'ITGB2', 'FOXM1', 'EGFR', 'CDH5', 'CDH4', 'CDH1', 'CDH20', 'MYC', 'ITGAX', 'ITGB8', 'HRAS', 'TEAD2', 'TEAD3', 'NTRK1', 'PDGFRA', 'NGFR', 'LATS2', 'PRKAR1A', 'ITGA10', 'CDH11', 'ITGA8', 'ITGA6', 'FGFR4', 'CDH17', 'CD44', 'EPHA2', 'CDH19']",0.6632038790297115,0,0,32
116,Statin inhibition of cholesterol production WP430,0.13061400673590243,1.828281730943328,3.721483586520664,"['ABCA1', 'APOC2', 'APOC1', 'LPL', 'APOA1', 'HMGCR', 'APOE', 'ACSS1']",0.6632038790297115,0,0,8
117,Toll-like Receptor Signaling Pathway WP75,0.136908191673275,1.3480328461775462,2.6804887839986384,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'PIK3R5', 'NFKBIA', 'TLR1', 'TOLLIP', 'IL1B', 'IRF7', 'TLR9', 'CCL3', 'SPP1', 'MAP3K8', 'TLR7', 'FADD', 'CD14', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2', 'MAPK3']",0.6892215803039229,0,0,24
118,Bile acids synthesis and enterohepatic circulation  WP4389,0.1444818875043122,2.5588250189921498,4.9503057611292425,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.6962817024931521,0,0,4
119,Estrogen Receptor Pathway WP2881,0.1444818875043122,2.5588250189921498,4.9503057611292425,"['JUN', 'PDK4', 'CYP1B1', 'PPARA']",0.6962817024931521,0,0,4
120,PTF1A related regulatory pathway WP4147,0.1444818875043122,2.5588250189921498,4.9503057611292425,"['KAT2B', 'NOTCH1', 'HES1', 'FGF10']",0.6962817024931521,0,0,4
121,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.1444818875043122,2.5588250189921498,4.9503057611292425,"['LFNG', 'NOTCH1', 'TBX6', 'DLL3']",0.6962817024931521,0,0,4
122,Tgif disruption of Shh signaling WP3674,0.1444818875043122,2.5588250189921498,4.9503057611292425,"['TGIF2', 'FGF8', 'NODAL', 'GLI3']",0.6962817024931521,0,0,4
123,TGF-beta Receptor Signaling WP560,0.14959276857026965,1.4547070501869892,2.763708537330339,"['JUN', 'FST', 'LEF1', 'SMAD6', 'RUNX3', 'LTBP1', 'THBS1', 'TGFBR2', 'TGFBR3', 'BAMBI', 'SPP1', 'ZNF423', 'HRAS', 'ENG', 'MAPK3']",0.6962817024931521,0,0,15
124,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.15131419001548976,3.198227848101266,6.0395234748691715,"['CYP2J2', 'COX8A', 'COX5A']",0.6962817024931521,0,0,3
125,Composition of Lipid Particles WP3601,0.15131419001548976,3.198227848101266,6.0395234748691715,"['APOA1', 'LPL', 'APOE']",0.6962817024931521,0,0,3
126,FTO Obesity Variant Mechanism WP3407,0.15131419001548976,3.198227848101266,6.0395234748691715,"['TBX1', 'PRDM16', 'UCP1']",0.6962817024931521,0,0,3
127,let-7 inhibition of ES cell reprogramming WP3299,0.15131419001548976,3.198227848101266,6.0395234748691715,"['EGR1', 'MYC', 'KLF4']",0.6962817024931521,0,0,3
128,Metabolism of alpha-linolenic acid WP4586,0.15131419001548976,3.198227848101266,6.0395234748691715,"['ALOX5', 'ALOX15', 'PTGS2']",0.6962817024931521,0,0,3
129,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.15623637281392255,1.5997971088004057,2.9698396888340204,"['FKBP10', 'ADAMTS2', 'COL1A2', 'P4HA1', 'CREB3L1', 'SERPINF1', 'LRP5', 'SERPINH1', 'TNFRSF11B', 'SP7']",0.7107856175179664,0,0,10
130,Aryl Hydrocarbon Receptor Netpath WP2586,0.1578278739656136,1.4857142857142858,2.7430003641030383,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'PTGS2', 'EGFR', 'HPGDS', 'MYC', 'CDC37', 'CDK2', 'CYP1B1', 'HRAS']",0.7107856175179664,0,0,13
131,Dopaminergic Neurogenesis WP2855,0.15985205041049377,1.9193311375728401,3.519106263158783,"['NEUROD1', 'FGF8', 'ALDH1A1', 'GLI1', 'SLC18A2', 'GLI2']",0.7107856175179664,0,0,6
132,Serotonin and anxiety WP3947,0.15985205041049377,1.9193311375728401,3.519106263158783,"['POMC', 'GABRA1', 'ARC', 'PLEK', 'CRH', 'TRPV1']",0.7107856175179664,0,0,6
133,RAS and bradykinin pathways in COVID-19 WP4969,0.1604999781492182,1.7062610899873256,3.121538926249837,"['CYP24A1', 'VDR', 'F12', 'IL1B', 'REN', 'CYP3A4', 'PRKG1', 'AGT']",0.7107856175179664,0,0,8
134,Differentiation Pathway WP2848,0.17426987021766518,1.476782542501903,2.580160918962992,"['CSF1R', 'CNTF', 'TPO', 'NOTCH1', 'FGF8', 'CSF1', 'HGF', 'FST', 'FGF2', 'DKK1', 'NODAL', 'FGF10']",0.7660071161060059,0,0,12
135,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.17744170135675638,1.999113475177305,3.4566934324089966,"['RYR1', 'CCKBR', 'CD38', 'CCK', 'RYR3']",0.7684791330818347,0,0,5
136,Osteoclast Signaling WP12,0.17744170135675638,1.999113475177305,3.4566934324089966,"['AIMP2', 'ATP6V1G1', 'GPR68', 'SPP1', 'TNFRSF11B']",0.7684791330818347,0,0,5
137,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.19283300101622378,1.4663876204972095,2.4135724677201456,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'BCL2A1', 'IGFBP2', 'PGK1', 'PMAIP1', 'BAX', 'SLC2A3', 'PTGS2']",0.8187963921659046,0,0,11
138,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.19323038796444947,1.5994930291508238,2.6293619359289813,"['NFKBIA', 'ZAP70', 'GSK3A', 'CD8B', 'NFATC2', 'PTPN6', 'CALM1', 'CALM2']",0.8187963921659046,0,0,8
139,Unfolded protein response WP4925,0.19323038796444947,1.5994930291508238,2.6293619359289813,"['PPP1R15A', 'XBP1', 'HSPA5', 'IL1B', 'DDIT3', 'TNFRSF10B', 'PMAIP1', 'TXNIP']",0.8187963921659046,0,0,8
140,Modulators of TCR signaling and T cell activation WP5072,0.19751834129947615,1.347325642019705,2.185259567736049,"['CDKN1B', 'NDUFB10', 'TNFAIP3', 'RHOH', 'RNF7', 'VAV1', 'ZFP36L1', 'NFKBIA', 'ZAP70', 'FIBP', 'CD5', 'ELOB', 'MAP3K8', 'PTPN6', 'CD247', 'CARD11']",0.8291804950948726,0,0,16
141,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1999042959311917,1.7447082939862266,2.808834752709643,"['SPP1', 'HSPB1', 'PDLIM5', 'TLR4', 'EGFR', 'ETS2']",0.8291804950948726,0,0,6
142,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.1999042959311917,1.7447082939862266,2.808834752709643,"['CDKN1A', 'CYP24A1', 'SPP1', 'ALPL', 'ROS1', 'NFKB2']",0.8291804950948726,0,0,6
143,Neural Crest Differentiation WP2064,0.20174691751088136,1.2592366972783298,2.0157121257352926,"['NOTCH2', 'NOTCH3', 'TCF7L1', 'NOTCH1', 'MIA', 'DLX5', 'WNT8A', 'ZIC5', 'TBX6', 'FGF2', 'BMP7', 'GFAP', 'NFKB2', 'DLL3', 'FGF8', 'CDH1', 'PAX7', 'MYC', 'HEY2', 'ZIC1', 'HES1', 'SOX9', 'HES5', 'SOX5']",0.8309715693280358,0,0,24
144,Ovarian infertility WP34,0.20467484733366392,1.515333084231878,2.4038223768673905,"['EGR1', 'CEBPB', 'CDKN1B', 'VDR', 'GJA4', 'MSH5', 'PGR', 'BMPR1B', 'PRLR']",0.8371769797189448,0,0,9
145,22q11.2 copy number variation syndrome WP4657,0.20858045644692472,1.2276904284093884,1.924319336031559,"['FOXC1', 'OAT', 'LRRC74B', 'RTN4', 'EGFR', 'CYP26B1', 'FGF8', 'MRPL40', 'RELN', 'CLTCL1', 'RCC1', 'HES1', 'DRD2', 'PRODH', 'TBX1', 'RANBP1', 'VWF', 'SERPIND1', 'GP1BA', 'SLC7A4', 'ACTA2', 'CLDN5', 'CYP26A1', 'ACTC1', 'THAP7', 'ALDH1A2', 'RAN', 'FGF10']",0.8415716477352086,0,0,28
146,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2108464221682268,1.1028732120491933,1.7167603087745307,"['NCF1', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'TUBB8', 'CDH5', 'GJA1', 'RPS6KA5', 'RPL18A', 'CFL1', 'CHAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'SARS', 'CYBB', 'DKK1', 'KATNAL2', 'TXNIP', 'PRKD2', 'RPL27', 'PRKD1', 'RPL26', 'ERG', 'ATP6V0D1', 'DSC1', 'EPHA2', 'SET', 'PLA2G5', 'FOXO4', 'TXN', 'ADRB2', 'GATA2', 'ACACB', 'FUT1', 'FOXO1', 'LDHA', 'PGK1', 'IGFBP7', 'FADD', 'EGR1', 'JUN', 'SDF2L1', 'EGR3', 'TNFRSF10C', 'NFATC2', 'NFATC1', 'BMX', 'SELE', 'QKI', 'NFKBIA', 'MOV10', 'NR4A1', 'NR4A3', 'ALB', 'CYCS', 'HYOU1', 'EIF4G2', 'FLT1', 'ITGB5', 'HSPB1', 'SHB', 'HERPUD1', 'RND1', 'TUBA1C', 'TMSB4X', 'RPLP2', 'ELOC', 'ADAMTS9', 'CLIC1', 'HRAS', 'CGNL1', 'PRKG1', 'DUSP5', 'HSP90AA1', 'SSR4', 'MMP2', 'GAB1', 'RHOC', 'EPN1', 'MMP14', 'RCN1', 'TAL1', 'RHOJ', 'ALDOA', 'GAPDH', 'FJX1', 'ENG', 'ARF6', 'KANK1', 'PTGS2', 'APOLD1', 'PTPRZ1', 'DNAJB4', 'CCL2', 'DNAJB9', 'CCT7', 'ABCF2', 'MAPK3', 'RAB11A', 'DNAJA1', 'FMNL3', 'PTPN6', 'HSPA1A']",0.8415716477352086,0,0,106
147,Matrix Metalloproteinases WP129,0.21616460318697883,1.599341104916371,2.4497349359973897,"['MMP14', 'MMP16', 'MMP26', 'MMP2', 'TIMP2', 'MMP19', 'MMP21']",0.8415716477352086,0,0,7
148,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2164687596248769,1.3331640426612494,2.0401529853490885,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'HSPA5', 'HSPB1', 'TNFRSF10B', 'RNF7', 'YBX3', 'THBS1', 'SOCS3', 'CASP7', 'ERBB3', 'APOE', 'VIM']",0.8415716477352086,0,0,15
149,Benzo(a)pyrene metabolism WP696,0.2196395620887386,2.3984810126582277,3.635539401280359,"['EPHX1', 'CYP1B1', 'CYP3A4']",0.8415716477352086,0,0,3
150,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2196395620887386,2.3984810126582277,3.635539401280359,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.8415716477352086,0,0,3
151,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.2196395620887386,2.3984810126582277,3.635539401280359,"['HEY1', 'VEGFC', 'HES1']",0.8415716477352086,0,0,3
152,Nanomaterial-induced inflammasome activation WP3890,0.2196395620887386,2.3984810126582277,3.635539401280359,"['IL1B', 'CASP1', 'TLR4']",0.8415716477352086,0,0,3
153,Peroxiredoxin 2 induced ovarian failure WP4873,0.2196395620887386,2.3984810126582277,3.635539401280359,"['STAR', 'CYP11A1', 'BAX']",0.8415716477352086,0,0,3
154,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.22146622308821282,1.4076204972095383,2.121967056661834,"['CREB3', 'STAR', 'CYP11A1', 'CREB3L1', 'HSD3B1', 'ITPR2', 'CALM3', 'REN', 'CALM1', 'CALM2', 'AGT']",0.8415716477352086,0,0,11
155,Tryptophan metabolism WP465,0.22146622308821282,1.4076204972095383,2.121967056661834,"['CYP2J2', 'TPH1', 'HAAO', 'KYNU', 'ALDH1A2', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.8415716477352086,0,0,11
156,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.22486473090829434,1.7768490374873354,2.651514087772099,"['TERT', 'CDH1', 'MYC', 'ALPL', 'ITGA6']",0.8490085032370857,0,0,5
157,PI3K-Akt signaling pathway WP4172,0.23526802301433858,1.1120422898401239,1.6091584337611005,"['CDKN1A', 'CDKN1B', 'CHRM1', 'CSF3R', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'TNC', 'FGF2', 'GYS2', 'GYS1', 'FGF7', 'CCND3', 'FGF8', 'MYC', 'CREB3L1', 'TNR', 'ITGB8', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'SYK', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'CDC37', 'COL4A6', 'ITGA8', 'COL4A5', 'ITGA6', 'COL6A6', 'TLR4', 'EPHA2', 'TLR2', 'CSF1R', 'PHLPP1', 'PKN3', 'LAMA1', 'LPAR1', 'LPAR3', 'THBS1', 'PIK3R6', 'EGFR', 'THBS4', 'PIK3R5', 'GNG10', 'GNG3', 'RELN', 'PDGFC', 'SPP1', 'MAPK3', 'NTRK1', 'NGFR', 'ANGPT2', 'LAMB3', 'BDNF', 'LAMB2', 'BAD', 'VEGFC', 'GNG12', 'GNG11', 'FGF17', 'EFNA3', 'COL1A2', 'IL7', 'ITGA10', 'CDK2', 'COL9A1', 'FGFR4', 'PIK3AP1', 'FGF10']",0.8731957224570307,0,0,75
158,Cell migration and invasion through p75NTR WP4561,0.2379703674748244,1.4394523326572009,2.066490895805804,"['NGFR', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'MMP2', 'PARD3', 'CDH11']",0.8731957224570307,0,0,9
159,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.2412768837085733,1.2970296350184618,1.8441298479221566,"['JUN', 'FST', 'LEF1', 'SMAD6', 'RUNX3', 'LTBP1', 'THBS1', 'TGFBR2', 'TGFBR3', 'BAMBI', 'SPP1', 'ZNF423', 'HRAS', 'ENG', 'MAPK3']",0.8731957224570307,0,0,15
160,Aflatoxin B1 metabolism WP699,0.2421064342821015,3.197671475575804,4.535506355539458,"['EPHX1', 'CYP3A4']",0.8731957224570307,0,0,2
161,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.2421064342821015,3.197671475575804,4.535506355539458,"['CHRM1', 'CCKBR']",0.8731957224570307,0,0,2
162,BMP Signaling Pathway in Eyelid Development WP3927,0.2431308972545892,1.5991892576640487,2.2615019785712587,"['FOXC1', 'JUN', 'NOTCH1', 'EGFR', 'MAPK3', 'FGF10']",0.8731957224570307,0,0,6
163,Nanomaterial induced apoptosis WP2507,0.2431308972545892,1.5991892576640487,2.2615019785712587,"['CASP7', 'ENDOG', 'CASP6', 'BAX', 'CYCS', 'FADD']",0.8731957224570307,0,0,6
164,Proteoglycan biosynthesis WP4784,0.2431308972545892,1.5991892576640487,2.2615019785712587,"['CSGALNACT1', 'XYLT1', 'B3GALT6', 'CHST14', 'B4GALT7', 'CHST3']",0.8731957224570307,0,0,6
165,The influence of laminopathies on Wnt signaling WP4844,0.24554838323530598,1.3907971198271014,1.9530425308815895,"['CEBPA', 'CEBPB', 'TCF7L1', 'ICMT', 'CEBPD', 'LEF1', 'SPP1', 'HMGA2', 'HES1', 'HES5']",0.876533319549062,0,0,10
166,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.2549499572528429,1.8274427522338386,2.4975440786112184,"['TPO', 'CSF1', 'IRF8', 'IKZF1']",0.8925204610730116,0,0,4
167,Apoptosis WP254,0.25516026540578823,1.2216822343475446,1.6686510985264649,"['JUN', 'CRADD', 'CDKN2A', 'BAD', 'TNFRSF10B', 'TNFRSF1B', 'NFKBIA', 'CASP7', 'CASP6', 'CASP10', 'MYC', 'CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'PMAIP1', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.8925204610730116,0,0,21
168,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.25516026540578823,1.2216822343475446,1.6686510985264649,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'LRP5', 'FZD9', 'WNT16', 'KLF4', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'MYC', 'NOTUM']",0.8925204610730116,0,0,21
169,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.2560882137883514,1.4926001013684744,2.0332695747242417,"['ABCC3', 'JUN', 'ABCC2', 'SRXN1', 'EPHX1', 'HMOX1', 'ABCG2']",0.8925204610730116,0,0,7
170,Osteoblast differentiation WP4787,0.2616969046088765,1.174702254222635,1.5747686010472477,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'WNT8A', 'LRP5', 'FGF2', 'PIK3R6', 'GLI3', 'PIK3R5', 'GLI2', 'DLL3', 'FGF7', 'FGF8', 'HEY1', 'HEY2', 'SOX9', 'MAPK3', 'WNT10A', 'PRKCH', 'FZD2', 'PTCH1', 'FZD9', 'WNT9A', 'WNT16', 'SMO', 'PRKD1', 'BMPR1B', 'FGFR4', 'FGF10']",0.906702804791931,0,0,29
171,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.26714072756100427,1.2627970383042422,1.6668664430494038,"['CEBPA', 'CDKN1A', 'CEBPB', 'TCF7L1', 'NOTCH1', 'ICMT', 'MSTN', 'CEBPD', 'LEF1', 'HMGA2', 'TNFRSF11B', 'KAT2B', 'SPP1', 'HES1', 'HES5']",0.9201513949323481,0,0,15
172,Airway smooth muscle cell contraction WP4962,0.27544300954356926,1.5990374873353597,2.0617582146000313,"['RYR1', 'CD38', 'ADRB2', 'CALM1', 'CALM2']",0.9323904173630017,0,0,5
173,Galanin receptor pathway WP4970,0.27544300954356926,1.5990374873353597,2.0617582146000313,"['YAP1', 'POMC', 'CDKN1A', 'CDKN1B', 'UCP1']",0.9323904173630017,0,0,5
174,ID signaling pathway WP53,0.27544300954356926,1.5990374873353597,2.0617582146000313,"['PAX8', 'CDK2', 'ID3', 'ELK1', 'PAX2']",0.9323904173630017,0,0,5
175,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.2827367552809758,1.0931577922526585,1.3809195646252372,"['CDKN1A', 'CDKN1B', 'CHRM1', 'CSF3R', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'ITGB2', 'TNC', 'SLC2A2', 'SLC2A3', 'HIF3A', 'FGF2', 'GYS2', 'GYS1', 'FGF7', 'FGF8', 'CREB3L1', 'ITGAX', 'TNR', 'ITGB8', 'PELO', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'CDC37', 'COL4A6', 'ITGA8', 'ITGA6', 'EPHA2', 'PFKFB1', 'CSF1R', 'PHLPP1', 'EPAS1', 'LAMA1', 'LPAR1', 'LPAR3', 'THBS1', 'EGFR', 'FOXO1', 'THBS4', 'PIK3R5', 'GNG10', 'GNG3', 'RELN', 'PDGFC', 'SPP1', 'MAPK3', 'NGFR', 'ANGPT2', 'LAMB3', 'LAMB2', 'BAD', 'VEGFC', 'GNG12', 'GNG11', 'FGF17', 'EFNA3', 'COL1A2', 'COL5A3', 'ITGA10', 'FGFR4', 'FGF10']",0.9477694686385526,0,0,70
176,Ferroptosis WP4313,0.28320445921966936,1.3031456113647895,1.6440304826892702,"['PRNP', 'MAP1LC3A', 'GPX4', 'FTH1', 'ALOX15', 'HMOX1', 'CYBB', 'SAT2', 'SLC7A11', 'CP', 'FTL']",0.9477694686385526,0,0,11
177,GDNF/RET signaling axis WP4830,0.28872708884620635,1.4760577653914366,1.8336672490385577,"['FOXC1', 'EYA1', 'GFRA1', 'SPRY1', 'PAX2', 'GLI3']",0.9518662548847923,0,0,6
178,IL-3 signaling pathway WP286,0.2896987043674666,1.260106137517305,1.5611629418824535,"['CD86', 'LYN', 'JUN', 'SYK', 'YWHAB', 'BAD', 'CSF2RB', 'VAV1', 'HCK', 'INPP5D', 'PTPN6', 'HRAS', 'MAPK3']",0.9518662548847923,0,0,13
179,Dual hijack model of Vif in HIV infection WP3300,0.2925089849476187,1.918632911392405,2.358498491225506,"['ELOB', 'ELOC', 'RUNX1']",0.9518662548847923,0,0,3
180,HIF1A and PPARG regulation of glycolysis WP2456,0.2925089849476187,1.918632911392405,2.358498491225506,"['LDHA', 'TPI1', 'GAPDH']",0.9518662548847923,0,0,3
181,NAD Biosynthesis II (from tryptophan) WP2485,0.2925089849476187,1.918632911392405,2.358498491225506,"['KYNU', 'HAAO', 'KMO']",0.9518662548847923,0,0,3
182,Metapathway biotransformation Phase I and II WP702,0.296670656152939,1.133261035978566,1.3770624940721894,"['GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'CHST11', 'CYP11A1', 'CYP1B1', 'CHST13', 'CHST14', 'GAL3ST2', 'SULT4A1', 'CYP2J2', 'CHST8', 'GPX4', 'GPX3', 'EPHX1', 'CYP3A43', 'KCNAB1', 'FMO2', 'CYP4F11', 'HS3ST4', 'CYP39A1', 'CYP26A1', 'SULT1B1', 'CYP2A6', 'CYP24A1', 'NAT8L', 'CHST2', 'CHST3']",0.9588407028810279,0,0,34
183,Zinc homeostasis WP3529,0.2979080621854467,1.3992017232640648,1.694391809264104,"['SLC30A3', 'SLC30A2', 'SLC39A11', 'SLC39A5', 'SLC39A7', 'SLC39A12', 'SLC39A3']",0.9588407028810279,0,0,7
184,Senescence and Autophagy in Cancer WP615,0.29971078424123654,1.159180465775259,1.3967398059751661,"['CDKN1A', 'CEBPB', 'CDKN1B', 'CXCL1', 'CXCL14', 'THBS1', 'GABARAP', 'MAP1LC3A', 'IFI16', 'CCL3', 'IGFBP7', 'HRAS', 'SLC39A3', 'GABARAPL2', 'GABARAPL1', 'JUN', 'SERPINB2', 'GSN', 'IGFBP5', 'CDKN2A', 'HMGA1', 'MMP14', 'IL1B', 'IRF7', 'CD44']",0.9594002821635235,0,0,25
185,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.3045132378237091,1.3466213061170036,1.601187565787076,"['CNTF', 'IL1B', 'CXCL1', 'SOX9', 'FGF2', 'MYT1', 'GLI2', 'SOX5']",0.9695043085306198,0,0,8
186,ACE Inhibitor Pathway WP554,0.3152519054364577,1.5988857938718664,1.8457269950139303,"['MAS1', 'ATP6AP2', 'REN', 'AGT']",0.984342886530898,0,0,4
187,Genes targeted by miRNAs in adipocytes WP1992,0.3152519054364577,1.5988857938718664,1.8457269950139303,"['KCNE1', 'GJA1', 'TMSB4X', 'ERG']",0.984342886530898,0,0,4
188,LTF danger signal response pathway WP4478,0.3152519054364577,1.5988857938718664,1.8457269950139303,"['IL1B', 'CD14', 'TLR4', 'TLR2']",0.984342886530898,0,0,4
189,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.3178967672491567,1.2381006949276014,1.4188987815501164,"['ACTA2', 'ACTA1', 'ACTC1', 'ITGB5', 'ITGB4', 'CDH1', 'ITGB2', 'ITGB8', 'LIMD1', 'TEAD2', 'ACTG1', 'TEAD3']",0.984342886530898,0,0,12
190,Pathogenic Escherichia coli infection WP2272,0.32062639814737043,1.2102536656992102,1.3766377692017744,"['TUBB', 'ARPC5L', 'LY96', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1C', 'TUBB2A', 'CDH1', 'TUBB3', 'HCLS1', 'CD14', 'TLR5', 'TLR4']",0.984342886530898,0,0,14
191,B Cell Receptor Signaling Pathway WP23,0.3210770208853076,1.1459222087576877,1.3018527072041037,"['LYN', 'JUN', 'GSK3A', 'SYK', 'GAB1', 'DAPP1', 'NFATC2', 'ELK1', 'FOXO1', 'VAV1', 'NFKBIA', 'PTPRC', 'BCL6', 'MYC', 'INPP5D', 'BTK', 'PLCG2', 'BLNK', 'HCLS1', 'PTPN6', 'PIK3AP1', 'HRAS', 'CARD11', 'CD22']",0.984342886530898,0,0,24
192,Prader-Willi and Angelman Syndrome WP3998,0.3214590923967179,1.1994667343829355,1.3612567847275874,"['PCSK1', 'MAGEL2', 'DLX5', 'CDKN2A', 'BDNF', 'ATP10A', 'TYR', 'POMC', 'GABRR2', 'GABRR1', 'NDN', 'MKRN3', 'GHRL', 'CGA', 'GABRD']",0.984342886530898,0,0,15
193,DNA damage response WP707,0.3225435943980701,1.1750434354173689,1.3295815940701812,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CCNB2', 'CCND3', 'RAD51', 'CDK5', 'MYC', 'CHEK2', 'CDK2', 'CDK1', 'PMAIP1', 'CYCS', 'BAX', 'SFN', 'RAD9A']",0.984342886530898,0,0,18
194,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.33586759559076035,1.370516486300626,1.495285918983003,"['H3F3B', 'BCL6', 'H2AFZ', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.9999953612313965,0,0,6
195,One-carbon metabolism WP241,0.33586759559076035,1.370516486300626,1.495285918983003,"['ALDH1L1', 'AHCY', 'FOLH1', 'TCN2', 'DNMT3A', 'MAT2B']",0.9999953612313965,0,0,6
196,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.33586759559076035,1.370516486300626,1.495285918983003,"['GSDMD', 'NFKBIA', 'FCGR2A', 'IL1B', 'CGAS', 'NFKBIE']",0.9999953612313965,0,0,6
197,Physiological and pathological hypertrophy of the heart WP1528,0.3410106257459574,1.316791389642527,1.416659010328814,"['EDN1', 'JUN', 'LIFR', 'CALM1', 'CALM2', 'AGT', 'NFATC4']",0.9999953612313965,0,0,7
198,miR-517 relationship with ARCN1 and USP1 WP3596,0.34249628485085787,2.131612250063275,2.2840107349071874,"['CDKN1A', 'ARCN1']",0.9999953612313965,0,0,2
199,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.34249628485085787,2.131612250063275,2.2840107349071874,"['EGFR', 'MAPK3']",0.9999953612313965,0,0,2
200,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.34444858633747566,1.2791888466413182,1.363372828846362,"['CEBPA', 'CEBPB', 'GJB2', 'ERBB3', 'MYC', 'PGR', 'PRLR', 'EGFR']",0.9999953612313965,0,0,8
201,Melatonin metabolism and effects WP3298,0.34675312362465743,1.2514000352764794,1.3254106008808135,"['PER2', 'EDN1', 'CYP1B1', 'ADRB1', 'APOE', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.9999953612313965,0,0,9
202,Cardiac Progenitor Differentiation WP2406,0.3482671393057477,1.2300278975399441,1.2974155318923912,"['MESP1', 'PDGFRA', 'NOTCH1', 'ACTC1', 'CXCR4', 'PAX6', 'THY1', 'FGF2', 'DKK1', 'NODAL']",0.9999953612313965,0,0,10
203,Nephrotic syndrome WP4758,0.3492093482487756,1.213081054602075,1.2762627860119464,"['CUBN', 'ANLN', 'TRPC6', 'ITGB4', 'LAMB2', 'ARHGDIA', 'COL4A5', 'GPC5', 'EMP2', 'ARHGAP24', 'PAX2']",0.9999953612313965,0,0,11
204,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.3665225149875717,1.59873417721519,1.6046420229570322,"['CYP4A11', 'PPARA', 'CYP2C18']",0.9999953612313965,0,0,3
205,Trans-sulfuration pathway WP2333,0.3665225149875717,1.59873417721519,1.6046420229570322,"['AHCY', 'GOT1', 'MAT2B']",0.9999953612313965,0,0,3
206,Vitamin B12 Disorders WP4271,0.3665225149875717,1.59873417721519,1.6046420229570322,"['CUBN', 'TCN2', 'TCN1']",0.9999953612313965,0,0,3
207,Vitamin D Metabolism WP1531,0.3665225149875717,1.59873417721519,1.6046420229570322,"['CYP24A1', 'VDR', 'GC']",0.9999953612313965,0,0,3
208,miRNA regulation of DNA damage response WP1530,0.3738720883706135,1.1287839150908139,1.110544516378964,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CCNB2', 'CCND3', 'RAD51', 'CDK5', 'MYC', 'CHEK2', 'CDK2', 'CDK1', 'PMAIP1', 'CYCS', 'BAX', 'SFN', 'RAD9A']",0.9999953612313965,0,0,18
209,Bladder cancer WP2828,0.3840435656312803,1.1843773776312452,1.1334482984287968,"['CDKN1A', 'RPS6KA5', 'CDH1', 'CDKN2A', 'MYC', 'DAPK2', 'MMP2', 'THBS1', 'HRAS', 'EGFR']",0.9999953612313965,0,0,10
210,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.38470489170443645,1.1991632860040569,1.145535209301539,"['YAP1', 'FYB1', 'LATS2', 'RAB13', 'LPL', 'FOXO4', 'FOXO1', 'TEAD2', 'TEAD3']",0.9999953612313965,0,0,9
211,miRNAs involvement in the immune response in sepsis WP4329,0.38501170683297736,1.2181785261633171,1.162728912965186,"['NFKBIA', 'VCAM1', 'CCL3', 'IRF7', 'TLR7', 'TLR4', 'RELB', 'NFKB2']",0.9999953612313965,0,0,8
212,Acute viral myocarditis WP4298,0.3977761813242486,1.1047696076165827,1.018449307493736,"['EDN1', 'ENDOG', 'CD80', 'ITGB2', 'CXCR4', 'NOD2', 'AIF1', 'NFKB2', 'CASP7', 'CASP6', 'CASP1', 'RAC3', 'CYCS', 'BAX', 'TLR5', 'TLR4', 'TLR3', 'EIF4G2', 'MAPK3']",0.9999953612313965,0,0,19
213,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4046576541477954,1.1123013550374927,1.00631446101092,"['CDKN1A', 'JUN', 'CDKN1B', 'FZD2', 'FZD9', 'WNT16', 'ELK1', 'EGFR', 'ACTA1', 'MYC', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'NEFH', 'PFN2']",0.9999953612313965,0,0,16
214,G1 to S cell cycle control WP45,0.4046576541477954,1.1123013550374927,1.00631446101092,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'GADD45A', 'MYT1', 'CREB3', 'CCND3', 'TFDP2', 'MYC', 'CREB3L1', 'RPA3', 'POLE2', 'CDK2', 'CDK1', 'MCM4']",0.9999953612313965,0,0,16
215,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4046576541477954,1.1123013550374927,1.00631446101092,"['IFI27L2', 'JUN', 'PRKCH', 'VDR', 'NOD2', 'IFI44L', 'RELB', 'NFKB2', 'CYP24A1', 'OAS2', 'PLCG2', 'CCL2', 'HRAS', 'TLR4', 'TLR2', 'MAPK3']",0.9999953612313965,0,0,16
216,Neural Crest Cell Migration during Development WP4564,0.42005752137353186,1.1419876091445962,0.9905185082970157,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'CDH11', 'PIK3R6', 'EPHB4', 'F2RL2', 'PIK3R5']",0.9999953612313965,0,0,10
217,Base Excision Repair WP4752,0.42574350714212084,1.1627145984560434,0.9928631686030776,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE2', 'POLE3']",0.9999953612313965,0,0,8
218,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.42943132676308343,1.0872052845528455,0.9190074965573222,"['YAP1', 'ANGPT2', 'BAD', 'MMP2', 'TIE1', 'FOXO1', 'EGFR', 'NFKBIA', 'CASP7', 'RAD51', 'MYC', 'TNIP3', 'STMN1', 'BAX', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9999953612313965,0,0,17
219,Apoptosis Modulation by HSP70 WP384,0.4345125848710343,1.2297365754812564,1.0250227835826031,"['CASP7', 'CASP6', 'CYCS', 'FADD', 'HSPA1A']",0.9999953612313965,0,0,5
220,Nicotine Activity on Dopaminergic Neurons WP1602,0.4345125848710343,1.2297365754812564,1.0250227835826031,"['CHRNB2', 'CDK5', 'DRD2', 'DRD3', 'SLC18A2']",0.9999953612313965,0,0,5
221,Nucleotide metabolism WP404,0.4345125848710343,1.2297365754812564,1.0250227835826031,"['PRPS1', 'RRM2', 'POLD1', 'NME2', 'OAZ1']",0.9999953612313965,0,0,5
222,Phytochemical activity on NRF2 transcriptional activation WP3,0.4371553010910691,1.278906052165105,1.0582522562152783,"['AIMP2', 'CEBPB', 'HMOX1', 'SLC7A11']",0.9999953612313965,0,0,4
223,Circadian rhythm related genes WP3594,0.4374496561157728,1.0417577307602883,0.8613186782364736,"['TPH1', 'MAGEL2', 'PHLPP1', 'AHCY', 'CHRM1', 'SUV39H1', 'NPY2R', 'OPRL1', 'RORA', 'RELB', 'ATOH7', 'PROKR2', 'NFIL3', 'SIX3', 'RPS27A', 'DRD2', 'DRD3', 'SKP1', 'CHRNB2', 'KLF10', 'NTRK1', 'EGR1', 'NGFR', 'JUN', 'ZFHX3', 'EGR3', 'CARTPT', 'HCRTR2', 'NR2F6', 'HCRTR1', 'PER2', 'F7', 'STAR', 'ADORA2A', 'LEP', 'BHLHE40', 'CRH', 'ID3', 'UTS2', 'GHRL', 'AVP', 'PPARA', 'UBA52']",0.9999953612313965,0,0,43
224,TNF-alpha signaling pathway WP231,0.43867942339530125,1.065886542864411,0.8782759891484773,"['HSP90AA1', 'JUN', 'BAD', 'TNFAIP3', 'CYBA', 'TXN', 'TNFRSF1B', 'SELE', 'NFKB2', 'NFKBIA', 'CASP7', 'PSMD2', 'RFK', 'CDC37', 'CCL2', 'BAX', 'MAP3K8', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999953612313965,0,0,22
225,Neuroinflammation WP4919,0.4390119002290724,1.3702350813743218,1.128016925154728,"['NFKBIA', 'JUN', 'TLR4']",0.9999953612313965,0,0,3
226,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.4390119002290724,1.3702350813743218,1.128016925154728,"['MYOCD', 'KLF4', 'ELK1']",0.9999953612313965,0,0,3
227,Genotoxicity pathway WP4286,0.4395993558441355,1.0918333859652383,0.8973686031173114,"['IKBIP', 'PLK3', 'CDKN1A', 'CEBPD', 'GADD45A', 'PCDH8', 'TRIAP1', 'ACTA2', 'RPS27', 'BLOC1S2', 'HIST1H1E', 'HIST1H2BG', 'TRIM22', 'HIST1H2BC']",0.9999953612313965,0,0,14
228,Focal Adhesion WP306,0.44622734414542436,1.0359232435823027,0.835914141592575,"['SHC4', 'SHC3', 'FLT1', 'ITGB5', 'ITGB4', 'LAMA1', 'TNC', 'ELK1', 'THBS1', 'EGFR', 'THBS4', 'MYL12B', 'ACTG1', 'CCND3', 'RELN', 'PDGFC', 'SPP1', 'RAC3', 'TNR', 'ITGB8', 'HRAS', 'MAPK3', 'VAV3', 'PDGFRA', 'JUN', 'CAV3', 'VWF', 'LAMB3', 'CAV2', 'LAMB2', 'BAD', 'HGF', 'VEGFC', 'VAV1', 'FGR', 'MYL5', 'HCK', 'COL1A2', 'PARVG', 'COL5A3', 'ITGA10', 'COL4A6', 'ITGA8', 'ITGA6', 'MYL9', 'DOCK1']",0.9999953612313965,0,0,46
229,Netrin-UNC5B signaling pathway WP4747,0.44728826549868705,1.0962554826548736,0.8819945443274853,"['YAP1', 'CDH5', 'DCSTAMP', 'ROBO4', 'JUN', 'VCAM1', 'ITGB4', 'INPP5D', 'CCL2', 'ALPL', 'SELE', 'MAPK3']",0.9999953612313965,0,0,12
230,Hedgehog Signaling Pathway WP4249,0.4560058239757416,1.1025212729673712,0.8657544962753314,"['EVC2', 'EVC', 'SMO', 'SUFU', 'PTCH1', 'BOC', 'LRP2', 'GLI1', 'GLI3', 'GLI2']",0.9999953612313965,0,0,10
231,IL-5 signaling pathway WP127,0.4560058239757416,1.1025212729673712,0.8657544962753314,"['LYN', 'GSK3A', 'SPRED1', 'JUN', 'SYK', 'MYC', 'BTK', 'CSF2RB', 'ELK1', 'MAPK3']",0.9999953612313965,0,0,10
232,Pathways Regulating Hippo Signaling WP4540,0.4587099078398881,1.050592511813886,0.8187659082203707,"['NTRK1', 'PDGFRA', 'CSF1R', 'NGFR', 'TCF7L1', 'PRKCH', 'FLT1', 'LEF1', 'PRKAG2', 'EGFR', 'CDH5', 'CDH4', 'LATS2', 'CDH1', 'PRKAR1A', 'CDH20', 'CDH11', 'FGFR4', 'CDH17', 'TEAD2', 'EPHA2', 'TEAD3', 'CDH19']",0.9999953612313965,0,0,23
233,Ebola Virus Pathway on Host WP4217,0.45965011910803877,1.0418828528559485,0.8098447992383732,"['ICAM2', 'EGFR', 'ACTG1', 'RELB', 'SOCS3', 'SCIN', 'CLTCL1', 'HLA-DOA', 'HLA-DQA1', 'HLA-DPA1', 'MAPK3', 'VPS18', 'HLA-DRB5', 'GSN', 'CAV3', 'CD300A', 'CAV2', 'RHOC', 'MERTK', 'HLA-E', 'NFKB2', 'BST2', 'AXL', 'NEDD4', 'IRF7', 'HLA-DRA', 'ITGA6', 'TLR4', 'CLEC4G']",0.9999953612313965,0,0,29
234,Tumor suppressor activity of SMARCB1 WP4204,0.46621467571031994,1.1120736209841846,0.8486334705127918,"['H3F3B', 'SMO', 'CDKN2A', 'PTCH1', 'DPF3', 'GLI1', 'GLI3', 'GLI2']",0.9999953612313965,0,0,8
235,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.46627373958015533,1.0491321210579858,0.800469336644912,"['KLB', 'NOTCH1', 'BAD', 'UCP1', 'DIO3', 'ITPR2', 'TRH', 'FOXO1', 'TSHR', 'MC4R', 'SLCO1C1', 'POMC', 'CREB3', 'TPO', 'NHSL1', 'TG', 'PAX8', 'NPPA', 'ZNF516', 'PRDM16', 'HRAS']",0.9999953612313965,0,0,21
236,Striated Muscle Contraction Pathway WP383,0.4721284299059047,1.1190065889508363,0.8398191819304054,"['ACTA2', 'MYOM1', 'ACTA1', 'ACTC1', 'VIM', 'MYL9', 'ACTG1']",0.9999953612313965,0,0,7
237,DNA Mismatch Repair WP531,0.4788144248118082,1.1283923754452376,0.8309957394502627,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999953612313965,0,0,6
238,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.4788144248118082,1.1283923754452376,0.8309957394502627,"['TGFBR3', 'ANGPT2', 'LTBP1', 'MAPK3', 'TGFBR2', 'ENG']",0.9999953612313965,0,0,6
239,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4788144248118082,1.1283923754452376,0.8309957394502627,"['PTGES2', 'PTGS2', 'HRAS', 'EGFR', 'MAPK3', 'PLA1A']",0.9999953612313965,0,0,6
240,PPAR-alpha pathway WP2878,0.48657880997298175,1.141807786944565,0.8225085431247435,"['MYC', 'CYP4A11', 'CDK1', 'APOA1', 'PPARA']",0.9999953612313965,0,0,5
241,Transcription factor regulation in adipogenesis WP3599,0.48657880997298175,1.141807786944565,0.8225085431247435,"['CEBPA', 'CEBPB', 'CEBPD', 'LEP', 'FOXO1']",0.9999953612313965,0,0,5
242,ATM Signaling Pathway WP2516,0.4916046347371452,1.065686025868628,0.7567228378216315,"['NFKBIA', 'CDKN1A', 'JUN', 'RAD51', 'CRADD', 'GADD45A', 'CHEK2', 'CDK2', 'CDK1', 'RAD9A']",0.9999953612313965,0,0,10
243,Glycogen Synthesis and Degradation WP500,0.4916046347371452,1.065686025868628,0.7567228378216315,"['GYS2', 'GYS1', 'GSK3A', 'HKDC1', 'PYGM', 'PHKA1', 'CALM3', 'CALM1', 'CALM2', 'HK2']",0.9999953612313965,0,0,10
244,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.4916046347371452,1.065686025868628,0.7567228378216315,"['LYN', 'NFKBIA', 'HCK', 'CISH', 'MYC', 'BTK', 'RELB', 'MAPK3', 'NFKB2', 'CRLF2']",0.9999953612313965,0,0,10
245,miRNAs involved in DNA damage response WP1545,0.49595974242437135,1.1625497824535556,0.8152502649904447,"['CDKN1A', 'CCND3', 'CDKN1B', 'MYC']",0.9999953612313965,0,0,4
246,Overview of nanoparticle effects WP3287,0.49595974242437135,1.1625497824535556,0.8152502649904447,"['CCND3', 'HMOX1', 'BAX', 'PTGS2']",0.9999953612313965,0,0,4
247,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.49595974242437135,1.1625497824535556,0.8152502649904447,"['PTTG1', 'BUB1B', 'ANAPC11', 'MAD2L1']",0.9999953612313965,0,0,4
248,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.49595974242437135,1.1625497824535556,0.8152502649904447,"['ABCA1', 'HMGCS1', 'HMGCR', 'PPARA']",0.9999953612313965,0,0,4
249,Nuclear receptors WP170,0.49842115329292197,1.0656693711967546,0.7420361013295386,"['NR4A1', 'VDR', 'NR1I3', 'RORA', 'NR0B1', 'PGR', 'NR2F2', 'PPARA', 'NR2F6']",0.9999953612313965,0,0,9
250,Alpha 6 Beta 4 signaling pathway WP244,0.5060351751820812,1.0656527249683143,0.7258683901988974,"['LAMB3', 'LAMA1', 'ITGB4', 'LAMB2', 'GAB1', 'ITGA6', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,8
251,Alanine and aspartate metabolism WP106,0.5080350926308219,1.1988607594936709,0.811874205482545,"['GOT1', 'GAD1', 'ASPA']",0.9999953612313965,0,0,3
252,Biogenic Amine Synthesis WP550,0.5080350926308219,1.1988607594936709,0.811874205482545,"['TPH1', 'GAD1', 'PAH']",0.9999953612313965,0,0,3
253,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.5080350926308219,1.1988607594936709,0.811874205482545,"['IDI1', 'HMGCS1', 'HMGCR']",0.9999953612313965,0,0,3
254,Osteoblast Signaling WP322,0.5080350926308219,1.1988607594936709,0.811874205482545,"['PDGFRA', 'TNFRSF11B', 'PTH1R']",0.9999953612313965,0,0,3
255,Serotonin Transporter Activity WP1455,0.5080350926308219,1.1988607594936709,0.811874205482545,"['IL1R1', 'IL1B', 'TGFB1I1']",0.9999953612313965,0,0,3
256,Synaptic Vesicle Pathway WP2267,0.51181848615825,1.036833839675758,0.6944559980224022,"['NSF', 'RAB3A', 'SLC32A1', 'CLTCL1', 'SLC1A3', 'SLC17A6', 'ATP1A2', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1']",0.9999953612313965,0,0,12
257,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.51181848615825,1.036833839675758,0.6944559980224022,"['NFKBIA', 'ZAP70', 'JUN', 'IL5', 'PTPRC', 'NFATC2', 'MAP3K8', 'PTPN6', 'CALM1', 'CALM2', 'CARD11', 'MAPK3']",0.9999953612313965,0,0,12
258,Mesodermal commitment pathway WP2857,0.512671017812895,1.0112447834819802,0.6756338055407897,"['YAP1', 'FOXC1', 'LEF1', 'FGF8', 'ZIC2', 'ZIC3', 'RPL38', 'TEAD2', 'VAV3', 'TBX1', 'TCF7L1', 'SLC2A12', 'PBX3', 'HMGA2', 'PAX6', 'ZIC5', 'TBX6', 'ELP4', 'SMAD6', 'KLF4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'TBX3', 'ARL4A', 'MEIS1', 'PRKAR1A', 'BHLHE40', 'RGS10', 'NODAL']",0.9999953612313965,0,0,31
259,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5161323850555448,1.022992125984252,0.676598794093522,"['HSPA8', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1C', 'PSMD7', 'TUBB2A', 'TUBB3', 'PSMD2', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.9999953612313965,0,0,16
260,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5188599088691447,1.034276419852568,0.6786108484793235,"['PDGFRA', 'CDKN1A', 'FGF7', 'HSP90AA1', 'JUN', 'CDKN2A', 'MMP2', 'TNFSF10', 'BAX', 'ELK1', 'EGFR']",0.9999953612313965,0,0,11
261,Pyrimidine metabolism WP4022,0.5196819761742335,1.0148559805310378,0.6642620461130859,"['CDA', 'RRM2', 'POLR2J2', 'NME2', 'UPB1', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLD1', 'POLE2', 'POLE3', 'POLR2E', 'CMPK2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999953612313965,0,0,20
262,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5254663323577669,1.2787648696532523,0.8228457546500433,"['IL1B', 'CASP1']",0.9999953612313965,0,0,2
263,LDLRAD4 and what we know about it WP4904,0.5254663323577669,1.2787648696532523,0.8228457546500433,"['NEDD4', 'TGFBR2']",0.9999953612313965,0,0,2
264,Mevalonate pathway WP3963,0.5254663323577669,1.2787648696532523,0.8228457546500433,"['HMGCS1', 'HMGCR']",0.9999953612313965,0,0,2
265,"Phase I biotransformations, non P450 WP136",0.5254663323577669,1.2787648696532523,0.8228457546500433,"['PON3', 'PON2']",0.9999953612313965,0,0,2
266,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5254663323577669,1.2787648696532523,0.8228457546500433,"['NFKBIA', 'MUC1']",0.9999953612313965,0,0,2
267,SARS-CoV-2 and COVID-19 Pathway WP4846,0.5254663323577669,1.2787648696532523,0.8228457546500433,"['NRP1', 'TLR7']",0.9999953612313965,0,0,2
268,The alternative pathway of fetal androgen synthesis WP4524,0.5254663323577669,1.2787648696532523,0.8228457546500433,"['STAR', 'CYP11A1']",0.9999953612313965,0,0,2
269,Development of ureteric collection system WP5053,0.526594262392818,1.0312272463246424,0.6613517390360393,"['FOXC1', 'SMO', 'ITGA8', 'GFRA1', 'SPRY1', 'GLI1', 'ETV4', 'GLI3', 'PAX2', 'GLI2']",0.9999953612313965,0,0,10
270,Neural Crest Cell Migration in Cancer WP4565,0.526594262392818,1.0312272463246424,0.6613517390360393,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'CDH11', 'PIK3R6', 'EPHB4', 'F2RL2', 'PIK3R5']",0.9999953612313965,0,0,10
271,IL-4 signaling pathway WP395,0.543322268517613,1.0094686093564285,0.6158289888714779,"['NFKBIA', 'CEBPA', 'SOCS3', 'CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'BAD', 'INPP5D', 'PTPN6', 'ELK1', 'MAPK3']",0.9999953612313965,0,0,12
272,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5439675286131728,0.9989193999491482,0.6082077836247612,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'LRP5', 'FZD9', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'MYC', 'NOTUM']",0.9999953612313965,0,0,20
273,CAMKK2  Pathway WP4874,0.5448608459630941,1.0229455006337136,0.6211579235044445,"['FIS1', 'MAP1LC3A', 'VCAM1', 'HMOX1', 'NFATC2', 'CALM1', 'CALM2', 'MAPK3']",0.9999953612313965,0,0,8
274,Type 2 papillary renal cell carcinoma WP4241,0.5448608459630941,1.0229455006337136,0.6211579235044445,"['CDKN1A', 'EGLN3', 'EGLN2', 'EPAS1', 'TFEB', 'COL21A1', 'ELOB', 'ELOC']",0.9999953612313965,0,0,8
275,Endometrial cancer WP4155,0.5501974258070176,0.9989207719654647,0.5968332940267397,"['CDKN1A', 'TCF7L1', 'GADD45B', 'BAD', 'GADD45A', 'LEF1', 'FGF2', 'ELK1', 'EGFR', 'CDH1', 'MYC', 'BAX', 'CTNNA2', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,15
276,FOXA2 pathway WP5066,0.5519515083123165,1.0655862243605976,0.6332726545282242,"['ABCC3', 'SLCO1B1', 'ABCC2', 'FOXO1']",0.9999953612313965,0,0,4
277,Glutathione metabolism WP100,0.5519515083123165,1.0655862243605976,0.6332726545282242,"['GGT5', 'GPX4', 'GPX3', 'GGT2']",0.9999953612313965,0,0,4
278,MAPK pathway in congenital thyroid cancer WP4928,0.5519515083123165,1.0655862243605976,0.6332726545282242,"['JUN', 'MYC', 'ELK1', 'MAPK3']",0.9999953612313965,0,0,4
279,NOTCH1 regulation of endothelial cell calcification WP3413,0.5519515083123165,1.0655862243605976,0.6332726545282242,"['NOTCH1', 'LPAR1', 'ALPL', 'DLL3']",0.9999953612313965,0,0,4
280,Type II diabetes mellitus WP1584,0.5519515083123165,1.0655862243605976,0.6332726545282242,"['SURF1', 'KCNJ11', 'SLC2A2', 'PIK3R5']",0.9999953612313965,0,0,4
281,SARS-CoV-2 mitochondrial interactions WP5038,0.5559490875211277,1.0171174492005715,0.5971278455264253,"['IFIH1', 'IRF7', 'CGAS', 'TLR7', 'PHB', 'TLR3', 'NFKB2']",0.9999953612313965,0,0,7
282,Nicotine Metabolism WP1600,0.5580794687904507,1.5984311740890689,0.9322912314404451,['CYP2A6'],0.9999953612313965,0,0,1
283,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5607426747733125,0.9989221405021557,0.5778696345770672,"['CDKN1A', 'CASP7', 'JUN', 'RRM2', 'MYC', 'MYOF', 'LEF1', 'PTGS2', 'CD44', 'MAPK3']",0.9999953612313965,0,0,10
284,Metabolic reprogramming in colon cancer WP4290,0.5607426747733125,0.9989221405021557,0.5778696345770672,"['ACLY', 'LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'SUCLG2', 'SLC1A5', 'ALDOB', 'GAPDH']",0.9999953612313965,0,0,10
285,Wnt signaling WP428,0.5612408700867623,0.9865071283095723,0.5698115555652761,"['LEF1', 'LRP5', 'CXXC4', 'NKD1', 'FRAT1', 'CCND3', 'FRAT2', 'MYC', 'GPC4', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'CSNK2A3', 'SERPINF1', 'FZD9', 'NFATC2', 'NFATC1', 'WNT16', 'DKK1', 'NFATC4', 'SFRP4', 'SFRP2', 'DAAM2', 'NOTUM']",0.9999953612313965,0,0,25
286,Photodynamic therapy-induced unfolded protein response WP3613,0.5689463698380152,1.0094542157268012,0.5693009882179687,"['PPP1R15A', 'NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9']",0.9999953612313965,0,0,6
287,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['SST', 'DKK1', 'FOXO1']",0.9999953612313965,0,0,3
288,Cancer immunotherapy by CTLA4 blockade WP4582,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['CD86', 'CD80', 'PTPN6']",0.9999953612313965,0,0,3
289,Iron metabolism in placenta WP2007,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['HEPHL1', 'FTH1', 'HAMP']",0.9999953612313965,0,0,3
290,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['MYC', 'PGR', 'VIM']",0.9999953612313965,0,0,3
291,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['JUN', 'RYR3', 'MAPK3']",0.9999953612313965,0,0,3
292,Purine metabolism WP4792,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['PRPS1', 'XDH', 'APRT']",0.9999953612313965,0,0,3
293,RalA downstream regulated genes WP2290,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['RAC3', 'YBX3', 'HRAS']",0.9999953612313965,0,0,3
294,Serotonin and anxiety-related events WP3944,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['ARC', 'PLEK', 'CRH']",0.9999953612313965,0,0,3
295,Sulfation Biotransformation Reaction WP692,0.5722961129666873,1.0655696202531646,0.5946930640873126,"['SULT1C2', 'SULT1B1', 'SULT4A1']",0.9999953612313965,0,0,3
296,Gastrin signaling pathway WP4659,0.582391455690848,0.974398936962893,0.5267721995781403,"['CDKN1A', 'CDKN1B', 'PTGS2', 'ELK1', 'FOXO1', 'EGFR', 'KAT5', 'CDH1', 'MYC', 'HRAS', 'MAPK3', 'CHGA', 'EGR1', 'JUN', 'PRKCH', 'SERPINB2', 'ANXA2', 'CDKN2A', 'BAD', 'KLF4', 'NFKBIA', 'CCKBR', 'PRKD2', 'PRKD1', 'CD44']",0.9999953612313965,0,0,25
297,miRNA targets in ECM and membrane receptors WP2911,0.5846492844612635,0.9989235055724417,0.5361653242885455,"['COL1A2', 'ITGB5', 'LAMB2', 'COL5A3', 'THBS1']",0.9999953612313965,0,0,5
298,Endothelin Pathways WP2197,0.595576848078911,0.9728178232221953,0.5041383710237823,"['ADCY10', 'EDN1', 'RIIAD1', 'ATP2A2', 'ADRB1', 'CALM1', 'CALM2']",0.9999953612313965,0,0,7
299,GABA receptor Signaling WP4159,0.595576848078911,0.9728178232221953,0.5041383710237823,"['GABRQ', 'GABRA1', 'SLC32A1', 'GAD1', 'GABRE', 'GABRD', 'AP2M1']",0.9999953612313965,0,0,7
300,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5961167229369546,0.9648568731099726,0.4991385874552497,"['PDGFRA', 'DUSP2', 'CSF3R', 'IL10RA', 'LIFR', 'CSF2RB', 'OSMR', 'CSF2RA', 'MAPK15', 'EGFR', 'SOCS3', 'PTPRC', 'STMN1', 'IL21R', 'F2RL2', 'MAPK3']",0.9999953612313965,0,0,16
301,Corticotropin-releasing hormone signaling pathway WP2355,0.5982521195469491,0.9638681095213886,0.49518050314243617,"['GNAZ', 'HSP90AA1', 'HSD3B1', 'ELK1', 'TBX19', 'FOSL2', 'NFKBIA', 'POMC', 'CRHBP', 'NR4A1', 'GJA1', 'STAR', 'CYP11A1', 'CRH', 'PLCG2', 'FOSB', 'TLR4', 'RAPGEF3', 'MAPK3']",0.9999953612313965,0,0,19
302,Canonical NF-KB pathway WP4562,0.603118722596207,1.0655530245507467,0.538787526059288,"['NFKBIA', 'NFKBIE']",0.9999953612313965,0,0,2
303,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.603118722596207,1.0655530245507467,0.538787526059288,"['ELOB', 'ELOC']",0.9999953612313965,0,0,2
304,Phosphodiesterases in neuronal function WP4222,0.6039657379630213,0.9588429332656686,0.4834848587740291,"['ADCY10', 'ADCY9', 'PDE10A', 'ADORA2A', 'PDE6H', 'ADCY4', 'PDE3A', 'PDE6C', 'PDE5A', 'CHRFAM7A', 'PDE6A', 'DRD2']",0.9999953612313965,0,0,12
305,15q13.3 copy number variation syndrome WP4942,0.6044439296769628,0.9835401367434794,0.49515970973008994,"['TRPM1', 'KAT2B', 'SERPINH1', 'CHRFAM7A']",0.9999953612313965,0,0,4
306,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6044439296769628,0.9835401367434794,0.49515970973008994,"['YAP1', 'PBX3', 'TEAD2', 'TEAD3']",0.9999953612313965,0,0,4
307,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6044439296769628,0.9835401367434794,0.49515970973008994,"['CDH1', 'TNC', 'VIM', 'MAPK3']",0.9999953612313965,0,0,4
308,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6053873020935545,0.9588742393509128,0.4812463782674056,"['NFKBIA', 'CASP7', 'JUN', 'TNFRSF12A', 'CCL2', 'FADD', 'RELB', 'MAPK3', 'NFKB2']",0.9999953612313965,0,0,9
309,Alzheimer's disease WP2059,0.6055612487433293,0.9587801778907242,0.4809237221843769,"['ATP5MD', 'BAD', 'ATP2A2', 'ITPR2', 'LPL', 'RYR3', 'CASP7', 'CDK5', 'IL1B', 'CYCS', 'CALM3', 'FADD', 'APOE', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.9999953612313965,0,0,18
310,7-oxo-C and 7beta-HC pathways WP5064,0.6110284566530767,0.9589054978464656,0.4723681124970495,"['HSD11B1', 'HSD11B2', 'ACOT11', 'THEM5', 'ACOT6', 'ACOT4']",0.9999953612313965,0,0,6
311,Cannabinoid receptor signaling WP3869,0.6110284566530767,0.9589054978464656,0.4723681124970495,"['CNR2', 'ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.9999953612313965,0,0,6
312,Ethanol effects on histone modifications WP3996,0.6110284566530767,0.9589054978464656,0.4723681124970495,"['KAT2B', 'ALDH1A3', 'AHCY', 'ADH1B', 'ALDH1A2', 'ALDH1A1']",0.9999953612313965,0,0,6
313,Gastric Cancer Network 2 WP2363,0.6110284566530767,0.9589054978464656,0.4723681124970495,"['PLAC8', 'MYC', 'S100A6', 'COL9A1', 'CACYBP', 'EGFR']",0.9999953612313965,0,0,6
314,Notch Signaling WP268,0.6257385776933974,0.9400128298846803,0.44069926140543136,"['NOTCH2', 'LFNG', 'NOTCH3', 'KAT2B', 'NOTCH1', 'DTX3L', 'MFNG', 'HES1', 'HES5', 'DLL3']",0.9999953612313965,0,0,10
315,"GPCRs, Class B Secretin-like WP334",0.6296574302825225,0.940088801478038,0.4348656845397345,"['ADGRE1', 'ADGRE2', 'ADGRG2', 'GIPR', 'PTH1R']",0.9999953612313965,0,0,5
316,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6302591093786252,0.939936665372091,0.4338975670568807,"['CDKN1A', 'CDKN1B', 'CR1', 'TRPC6', 'KIRREL2', 'NOTCH1', 'ITGB4', 'LAMB2', 'CD80', 'LRP5', 'DKK1', 'PAX2', 'COL4A5', 'VIM', 'TLR4']",0.9999953612313965,0,0,15
317,Cysteine and methionine catabolism WP4504,0.6310346395053066,0.9589367088607595,0.4414892074575086,"['AHCY', 'GOT1', 'SQOR']",0.9999953612313965,0,0,3
318,Ganglio Sphingolipid Metabolism WP1423,0.6310346395053066,0.9589367088607595,0.4414892074575086,"['B3GALT1', 'B4GALNT1', 'FUT1']",0.9999953612313965,0,0,3
319,Homologous recombination WP186,0.6310346395053066,0.9589367088607595,0.4414892074575086,"['POLD4', 'RAD51', 'POLD1']",0.9999953612313965,0,0,3
320,Fluoropyrimidine Activity WP1601,0.6333074550040734,0.9322098327420172,0.42583276535066994,"['ABCC3', 'CDA', 'CYP2A6', 'RRM2', 'UPP2', 'UPB1', 'ABCG2']",0.9999953612313965,0,0,7
321,Copper homeostasis WP3286,0.6384209570243506,0.9278692010730878,0.416388175749536,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'COX17', 'XAF1', 'SOD3', 'FOXO1', 'ATOX1']",0.9999953612313965,0,0,9
322,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6384209570243506,0.9278692010730878,0.416388175749536,"['ACTA1', 'CASP7', 'JUN', 'CASP6', 'CASP10', 'HSPB1', 'CYCS', 'FADD', 'ACTG1']",0.9999953612313965,0,0,9
323,Retinoblastoma gene in cancer WP2446,0.6442636308839317,0.9340620233858669,0.41065782038386056,"['BARD1', 'CDT1', 'CDKN1A', 'CDKN1B', 'RRM2', 'H2AFZ', 'SUV39H1', 'TTK', 'CCNB2', 'ANLN', 'CCND3', 'TFDP2', 'MYC', 'RPA3', 'POLE2', 'STMN1', 'CDK2', 'CDK1', 'MCM4']",0.9999953612313965,0,0,19
324,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6507141479799804,0.9131709435737811,0.39237570165933855,"['TGFBR3', 'HGF', 'HRAS', 'EGFR', 'PIK3R5', 'TGFBR2']",0.9999953612313965,0,0,6
325,Monoamine Transport WP727,0.6507141479799804,0.9131709435737811,0.39237570165933855,"['ADORA2A', 'IL1R1', 'TGFB1I1', 'IL1B', 'TNFRSF11B', 'AGT']",0.9999953612313965,0,0,6
326,Methionine De Novo and Salvage Pathway WP3580,0.6529957024055278,0.9132149187859494,0.3891982545407575,"['AHCY', 'ODC1', 'TXN', 'MAT2B']",0.9999953612313965,0,0,4
327,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6529957024055278,0.9132149187859494,0.3891982545407575,"['FGF7', 'SUV39H1', 'CDC37', 'IGFBP7']",0.9999953612313965,0,0,4
328,Transcription co-factors SKI and SKIL protein partners WP4533,0.6529957024055278,0.9132149187859494,0.3891982545407575,"['LATS2', 'MERTK', 'TEAD2', 'TEAD3']",0.9999953612313965,0,0,4
329,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.6634037067061362,1.0655364372469636,0.43726585536779633,['FMO2'],0.9999953612313965,0,0,1
330,GABA metabolism (aka GHB) WP4157,0.6634037067061362,1.0655364372469636,0.43726585536779633,['PON3'],0.9999953612313965,0,0,1
331,Sulindac Metabolic Pathway WP2542,0.6634037067061362,1.0655364372469636,0.43726585536779633,['CYP1B1'],0.9999953612313965,0,0,1
332,Vitamin B6-dependent and responsive disorders WP4228,0.6634037067061362,1.0655364372469636,0.43726585536779633,['PNPO'],0.9999953612313965,0,0,1
333,IL-6 signaling pathway WP364,0.6698721908662699,0.8988019776876268,0.3601215006088727,"['SOCS3', 'HCK', 'BAD', 'GAB1', 'VIP', 'AGT', 'VAV1', 'MAPK3', 'NR2F6']",0.9999953612313965,0,0,9
334,Aspirin and miRNAs WP4707,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['PPARA', 'PTGS2']",0.9999953612313965,0,0,2
335,Estrogen metabolism WP697,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['CYP1B1', 'CYP3A4']",0.9999953612313965,0,0,2
336,FOXP3 in COVID-19 WP5063,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['CD86', 'CD80']",0.9999953612313965,0,0,2
337,Leptin and adiponectin WP3934,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['LEP', 'LEPR']",0.9999953612313965,0,0,2
338,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['AHCY', 'MAT2B']",0.9999953612313965,0,0,2
339,Supression of HMGB1 mediated inflammation by THBD WP4479,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['NFKBIA', 'THBD']",0.9999953612313965,0,0,2
340,Thiamine metabolic pathways WP4297,0.6707175751646451,0.9132588494775283,0.3647620978510026,"['BCKDK', 'SLC19A3']",0.9999953612313965,0,0,2
341,IL-7 signaling pathway WP205,0.6715582293889824,0.8877912867274569,0.35347814148742945,"['CDKN1B', 'BAD', 'IL7', 'MYC', 'MAPK3']",0.9999953612313965,0,0,5
342,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6715582293889824,0.8877912867274569,0.35347814148742945,"['GOT1', 'MDH2', 'SCO2', 'IL1B', 'HMGA1']",0.9999953612313965,0,0,5
343,Oncostatin M Signaling Pathway WP2374,0.6757298807452407,0.9030567203707791,0.35396379856664834,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'LIFR', 'OSMR', 'NFKBIA', 'SOCS3', 'CASP7', 'CDK2', 'CCL2', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,13
344,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.6839107723358601,0.8716915995397008,0.331179888838014,"['CDH1', 'TULP3', 'PMAIP1']",0.9999953612313965,0,0,3
345,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6839107723358601,0.8716915995397008,0.331179888838014,"['IFIH1', 'OAS1', 'CGAS']",0.9999953612313965,0,0,3
346,Small Ligand GPCRs WP247,0.6839107723358601,0.8716915995397008,0.331179888838014,"['CNR2', 'LPAR1', 'PTGDR']",0.9999953612313965,0,0,3
347,Chemokine signaling pathway WP3929,0.684857282875688,0.9214886566403263,0.34882474714933315,"['SHC4', 'CX3CR1', 'SHC3', 'NCF1', 'CXCR5', 'ADCY4', 'CXCR4', 'PRKX', 'CXCL13', 'CXCL14', 'CXCL5', 'CX3CL1', 'PIK3R5', 'PREX1', 'GNG10', 'GNG3', 'CCL3', 'HRAS', 'MAPK3', 'LYN', 'CCR1', 'VAV3', 'GNG12', 'GNG11', 'VAV1', 'NFKBIA', 'FGR', 'HCK', 'ADCY9', 'PARD3']",0.9999953612313965,0,0,30
348,Neovascularisation processes WP4331,0.6850945548823444,0.8815698614571041,0.3334083233640365,"['ACVRL1', 'NOTCH3', 'NOTCH1', 'CXCR4', 'EPHB4', 'RELB', 'MAPK3', 'NFKB2']",0.9999953612313965,0,0,8
349,Vitamin D-sensitive calcium signaling in depression WP4698,0.6850945548823444,0.8815698614571041,0.3334083233640365,"['TPH1', 'CHRM1', 'CALB1', 'GPX4', 'VDR', 'ITPR2', 'PVALB', 'GGT2']",0.9999953612313965,0,0,8
350,Cytosolic DNA-sensing pathway WP4655,0.6871073449331128,0.891734478912801,0.33463651383768056,"['NFKBIA', 'RNF125', 'CASP10', 'IL1B', 'CASP1', 'IRF7', 'POLR2E', 'CGAS', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999953612313965,0,0,12
351,IL17 signaling pathway WP2112,0.6878120583405826,0.8715940760531589,0.3261850614267713,"['CEBPB', 'CEBPD', 'IL17RE', 'IL17RD', 'IL17RB', 'MAPK3']",0.9999953612313965,0,0,6
352,Signal transduction through IL1R WP4496,0.6878120583405826,0.8715940760531589,0.3261850614267713,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'IL1B', 'IRAK3']",0.9999953612313965,0,0,6
353,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6896942667970534,0.8946636202081747,0.33237368230514797,"['EGR1', 'JUN', 'CDKN1B', 'KCNIP3', 'TSHR', 'MYL12B', 'CCND3', 'PAX8', 'MYC', 'APEX1', 'CDK2', 'CGA', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,14
354,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6973734975651585,0.8522663965560902,0.30718591185829847,"['CASP7', 'BAD', 'BAX', 'FADD']",0.9999953612313965,0,0,4
355,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6973734975651585,0.8522663965560902,0.30718591185829847,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,4
356,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6973734975651585,0.8522663965560902,0.30718591185829847,"['EGR1', 'RPS6KA5', 'ELK1', 'MAPK3']",0.9999953612313965,0,0,4
357,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6996347610431921,0.871496404204315,0.311295770408486,"['NFKBIA', 'BAD', 'IL1B', 'NPPA', 'PDE3A', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.9999953612313965,0,0,9
358,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7023505476847656,0.860364926507856,0.30398641056684733,"['IFIH1', 'NFKBIA', 'JUN', 'OAS1', 'OAS2', 'OAS3', 'TLR7']",0.9999953612313965,0,0,7
359,TLR4 Signaling and Tolerance WP3851,0.7101921990211763,0.8409987735295686,0.2878062998165615,"['NFKBIA', 'INPP5D', 'IRF7', 'IRAK3', 'TLR4']",0.9999953612313965,0,0,5
360,Melanoma WP4685,0.7131299836712233,0.8770515060555829,0.29652372056040255,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'ELK1', 'PREX2', 'CDH1', 'BAX', 'CALM3', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.9999953612313965,0,0,14
361,IL-2 signaling pathway WP49,0.7155424963529603,0.8521166032953105,0.28521560201576945,"['SOCS3', 'JUN', 'SYK', 'CISH', 'MYC', 'NMI', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,8
362,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7222110600706333,0.8336325883169385,0.2712956021009455,"['CDKN1B', 'BAD', 'TFEB', 'FOXO4', 'HRAS', 'FOXO1']",0.9999953612313965,0,0,6
363,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.724757857903852,0.8713006140634378,0.2804870626883555,"['TCF7L1', 'ITGB5', 'ITGB4', 'LEF1', 'ATP2A2', 'ACTG1', 'GJA1', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGA6', 'CTNNA2', 'CACNG1', 'CACNG4', 'CACNG5']",0.9999953612313965,0,0,15
364,Integrated Cancer Pathway WP1971,0.7276371710600151,0.8457970409259038,0.2689234920803641,"['BARD1', 'CDKN1A', 'CDKN1B', 'BAD', 'MYC', 'CHEK2', 'CDK2', 'CDK1', 'BAX']",0.9999953612313965,0,0,9
365,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.7286439265162982,0.7990382181726146,0.252951614457609,"['IL10RA', 'HMOX1']",0.9999953612313965,0,0,2
366,Nanoparticle triggered regulated necrosis WP2513,0.7286439265162982,0.7990382181726146,0.252951614457609,"['FADD', 'FTL']",0.9999953612313965,0,0,2
367,Biomarkers for pyrimidine metabolism disorders WP4584,0.73089847673287,0.7989873417721519,0.2504671204547935,"['NT5C', 'RRM2', 'UPB1']",0.9999953612313965,0,0,3
368,Cholesterol Biosynthesis Pathway WP197,0.73089847673287,0.7989873417721519,0.2504671204547935,"['IDI1', 'HMGCS1', 'HMGCR']",0.9999953612313965,0,0,3
369,Fatty acid transporters WP5061,0.73089847673287,0.7989873417721519,0.2504671204547935,"['FABP6', 'FABP7', 'ACSBG1']",0.9999953612313965,0,0,3
370,Leptin Insulin Overlap WP3935,0.73089847673287,0.7989873417721519,0.2504671204547935,"['SOCS3', 'LEP', 'LEPR']",0.9999953612313965,0,0,3
371,Tryptophan catabolism leading to NAD+ production WP4210,0.73089847673287,0.7989873417721519,0.2504671204547935,"['HAAO', 'KYNU', 'KMO']",0.9999953612313965,0,0,3
372,Amyotrophic lateral sclerosis (ALS) WP2447,0.7334494976985079,0.8284338570704511,0.25681162508255595,"['BAD', 'SLC1A2', 'CASP1', 'NEFL', 'BAX', 'NEFM', 'NEFH']",0.9999953612313965,0,0,7
373,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7334494976985079,0.8284338570704511,0.25681162508255595,"['JUN', 'HGF', 'GAB1', 'ELK1', 'HRAS', 'DOCK1', 'MAPK3']",0.9999953612313965,0,0,7
374,Notch Signaling Pathway Netpath WP61,0.7363153287322645,0.8519665059629535,0.26078423500826386,"['NOTCH2', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'MAML2', 'HEY1', 'MYC', 'HEY2', 'HES1', 'HES5', 'SKP1', 'DLL3']",0.9999953612313965,0,0,12
375,Endoderm differentiation WP2853,0.736929918249926,0.8890058872649165,0.2713801435561302,"['NOTCH1', 'ONECUT1', 'LEF1', 'WNT8A', 'FOXO1', 'GLI2', 'HHEX', 'ZIC3', 'TCEAL2', 'VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'TCF7L1', 'SLC2A12', 'PBX3', 'ZIC5', 'ELP4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'NME1', 'DAB2', 'RGS10', 'RAB38', 'NODAL']",0.9999953612313965,0,0,27
376,Benzene metabolism WP3891,0.7436304588983813,0.7990890688259109,0.23669902216654487,['EPHX1'],0.9999953612313965,0,0,1
377,MED and Pseudoachondroplasia genes WP4789,0.7436304588983813,0.7990890688259109,0.23669902216654487,['COL9A1'],0.9999953612313965,0,0,1
378,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.7436304588983813,0.7990890688259109,0.23669902216654487,['NRP1'],0.9999953612313965,0,0,1
379,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.7436304588983813,0.7990890688259109,0.23669902216654487,['FOXO1'],0.9999953612313965,0,0,1
380,Steroid Biosynthesis WP496,0.7436304588983813,0.7990890688259109,0.23669902216654487,['HSD3B1'],0.9999953612313965,0,0,1
381,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7538695776223309,0.7988345578920699,0.22569944069451547,"['HPGD', 'CYP4A11', 'TBXAS1', 'PLA2G5', 'PTGS2', 'PTGDR']",0.9999953612313965,0,0,6
382,Type II interferon signaling (IFNG) WP619,0.7538695776223309,0.7988345578920699,0.22569944069451547,"['SOCS3', 'OAS1', 'IL1B', 'CYBB', 'IRF8', 'PSMB9']",0.9999953612313965,0,0,6
383,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.762211425255593,0.7987835783071465,0.21689474408765602,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'IFI27', 'DDIT3', 'MAPK3']",0.9999953612313965,0,0,7
384,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7631233211850845,0.8191732183616536,0.22145171137508368,"['CD160', 'CXCL17', 'IRF7', 'CCL3', 'CCL2', 'CXCL1', 'TLR7', 'FADD', 'CXCL13', 'CXCL5']",0.9999953612313965,0,0,10
385,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7631233211850845,0.8191732183616536,0.22145171137508368,"['NFKBIA', 'RPS6KA5', 'IL1R1', 'MYC', 'TOLLIP', 'MKNK2', 'IRF7', 'MAP3K8', 'ELK1', 'MAPK3']",0.9999953612313965,0,0,10
386,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7658027189813725,0.8405950121621982,0.22429654663017423,"['CDKN1A', 'TCF7L1', 'JUN', 'GADD45B', 'BAD', 'GADD45A', 'LEF1', 'PTGS2', 'TGFBR2', 'MYC', 'RAC3', 'PMAIP1', 'CYCS', 'BAX', 'MAPK3']",0.9999953612313965,0,0,15
387,AGE/RAGE pathway WP2324,0.7680217129513967,0.8305482233502538,0.21921263413114242,"['JUN', 'NCF1', 'MMP2', 'MSN', 'FOXO4', 'FOXO1', 'EGFR', 'NFKBIA', 'LGALS3', 'MMP14', 'ALPL', 'CYCS', 'MAPK3']",0.9999953612313965,0,0,13
388,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.7721938757989232,0.7374683544303797,0.1906500431976108,"['RAB27A', 'SYTL4', 'SYTL3']",0.9999953612313965,0,0,3
389,Hypertrophy Model WP516,0.7721938757989232,0.7374683544303797,0.1906500431976108,"['NR4A3', 'MSTN', 'IL1R1']",0.9999953612313965,0,0,3
390,Mammalian disorder of sexual development WP4842,0.7721938757989232,0.7374683544303797,0.1906500431976108,"['EMX2', 'FST', 'SOX9']",0.9999953612313965,0,0,3
391,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7721938757989232,0.7374683544303797,0.1906500431976108,"['SFRP4', 'LEF1', 'DKK3']",0.9999953612313965,0,0,3
392,Urea cycle and metabolism of amino groups WP497,0.7734807178698853,0.7518805952363219,0.19312394269214833,"['OAT', 'CKM', 'ODC1', 'PYCR3']",0.9999953612313965,0,0,4
393,T-cell receptor (TCR) signaling pathway WP69,0.7744673398161959,0.8377852821279413,0.21412098596287152,"['VAV3', 'JUN', 'CD83', 'FYB1', 'NFATC2', 'NFATC1', 'VAV1', 'NFKBIA', 'ZAP70', 'IL1B', 'MAP3K8', 'CD247', 'VIM', 'HRAS', 'CARD11', 'MAPK3']",0.9999953612313965,0,0,16
394,"NAD metabolism, sirtuins and aging WP3630",0.7776680419967378,0.7101999493799038,0.17858370261502743,"['ROS1', 'FOXO1']",0.9999953612313965,0,0,2
395,Cell cycle WP179,0.7815017859689369,0.8583946521253532,0.21162676667669067,"['ANAPC13', 'CDKN1A', 'CDKN1B', 'YWHAB', 'TTK', 'CDC14A', 'ANAPC11', 'CCNB2', 'CCND3', 'PTTG1', 'PTTG2', 'MYC', 'CHEK2', 'SFN', 'YWHAG', 'SKP1', 'YWHAH', 'CDKN2D', 'GADD45B', 'GADD45A', 'CDKN2A', 'TFDP2', 'CDK2', 'CDK1', 'MCM4']",0.9999953612313965,0,0,25
396,miRNA regulation of prostate cancer signaling pathways WP3981,0.7828044505822738,0.7668203699011907,0.18777311214859552,"['NFKBIA', 'CDKN1A', 'CDKN1B', 'BAD', 'CREB3L1', 'FOXO1']",0.9999953612313965,0,0,6
397,Prion disease pathway WP3995,0.7828044505822738,0.7668203699011907,0.18777311214859552,"['PRNP', 'HSPA5', 'EBF1', 'ELK1', 'MAPK3', 'BATF']",0.9999953612313965,0,0,6
398,Integrin-mediated Cell Adhesion WP185,0.7892504749393678,0.8403923615293,0.19889696262965098,"['VAV3', 'SHC3', 'ITGAM', 'CAV3', 'ITGB5', 'CAV2', 'ITGB4', 'ITGB2', 'CAPNS1', 'ITGA10', 'SELENOP', 'ITGAX', 'ITGA8', 'RHO', 'RAC3', 'ITGB8', 'ITGA6', 'HRAS', 'DOCK1', 'TNS1']",0.9999953612313965,0,0,20
399,DNA Replication WP466,0.7947166107273435,0.7744671045051273,0.17794906835304675,"['POLD4', 'CDT1', 'POLD1', 'RPA3', 'POLE2', 'CDK2', 'MCM4', 'UBA52']",0.9999953612313965,0,0,8
400,Pathways in clear cell renal cell carcinoma WP4018,0.7996271580518031,0.8225933111603844,0.18393985371893046,"['PDGFRA', 'FLT1', 'TPI1', 'ENO2', 'ACACB', 'HK2', 'EGFR', 'LDHC', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'PFKM']",0.9999953612313965,0,0,17
401,Leptin signaling pathway WP2034,0.8024938653002635,0.8119711459830766,0.1786588788360108,"['GSK3A', 'CISH', 'BAD', 'ELK1', 'ACACB', 'FOXO1', 'SOCS3', 'CFL2', 'IL1B', 'LEP', 'LEPR', 'PLCG2', 'BAX', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,15
402,Effects of nitric oxide WP1995,0.804738990223685,0.6392206477732794,0.1388625611616474,['XDH'],0.9999953612313965,0,0,1
403,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.804738990223685,0.6392206477732794,0.1388625611616474,['GGT2'],0.9999953612313965,0,0,1
404,Hfe effect on hepcidin production WP3924,0.804738990223685,0.6392206477732794,0.1388625611616474,['HAMP'],0.9999953612313965,0,0,1
405,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.804738990223685,0.6392206477732794,0.1388625611616474,['CDKN1A'],0.9999953612313965,0,0,1
406,Metastatic brain tumor WP2249,0.804738990223685,0.6392206477732794,0.1388625611616474,['MYC'],0.9999953612313965,0,0,1
407,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.804738990223685,0.6392206477732794,0.1388625611616474,['SIX4'],0.9999953612313965,0,0,1
408,miRNA Biogenesis WP2338,0.804738990223685,0.6392206477732794,0.1388625611616474,['RAN'],0.9999953612313965,0,0,1
409,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.804738990223685,0.6392206477732794,0.1388625611616474,['ROBO4'],0.9999953612313965,0,0,1
410,Somatic sex determination WP4814,0.804738990223685,0.6392206477732794,0.1388625611616474,['SOX9'],0.9999953612313965,0,0,1
411,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8054414006852295,0.7100531780197519,0.15363053373705404,"['H3F3B', 'SUV39H1', 'LEF1', 'HIST1H3E']",0.9999953612313965,0,0,4
412,NRF2-ARE regulation WP4357,0.8054414006852295,0.7100531780197519,0.15363053373705404,"['AIMP2', 'CEBPB', 'HMOX1', 'SLC7A11']",0.9999953612313965,0,0,4
413,Lipid Metabolism Pathway WP3965,0.8063412759084788,0.7261444229529336,0.15630128495536474,"['ACLY', 'PRKAR1A', 'HILPDA', 'PRKAG2', 'ACSBG1']",0.9999953612313965,0,0,5
414,Translation Factors WP107,0.8068691660125302,0.7790898350271862,0.16718780753700876,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF1AY', 'EIF1AX', 'EEF1A2', 'EIF4H', 'EIF3CL', 'GSPT2', 'EIF1']",0.9999953612313965,0,0,10
415,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.8081402361153563,0.684737793851718,0.14586262297210886,"['EIF1AX', 'EIF3CL', 'EIF1']",0.9999953612313965,0,0,3
416,Pyrimidine metabolism and related diseases WP4225,0.8081402361153563,0.684737793851718,0.14586262297210886,"['NT5C', 'RRM2', 'UPB1']",0.9999953612313965,0,0,3
417,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8090799790663585,0.7372688117557639,0.15619593109869204,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC2', 'NFATC1', 'NFATC4']",0.9999953612313965,0,0,6
418,G13 Signaling Pathway WP524,0.8128123888921375,0.7454130765331982,0.15449055738625983,"['RTKN', 'CFL2', 'CFL1', 'ARHGDIG', 'PIP4K2A', 'CALM1', 'CALM2']",0.9999953612313965,0,0,7
419,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8128123888921375,0.7454130765331982,0.15449055738625983,"['GABRQ', 'NGFR', 'GABRA1', 'SLC12A5', 'BDNF', 'GABRE', 'GABRD']",0.9999953612313965,0,0,7
420,Small cell lung cancer WP4658,0.813114974626973,0.819872490690996,0.16961748308915658,"['CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMA1', 'LAMB2', 'GADD45A', 'PTGS2', 'FHIT', 'NFKBIA', 'MYC', 'CDK2', 'CKS2', 'COL4A6', 'COL4A5', 'CYCS', 'BAX', 'ITGA6', 'SKP1']",0.9999953612313965,0,0,19
421,Biomarkers for urea cycle disorders WP4583,0.8187423566004821,0.6391293343457353,0.1278168088253014,"['F7', 'GOT1']",0.9999953612313965,0,0,2
422,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8187423566004821,0.6391293343457353,0.1278168088253014,"['BMPR1B', 'SMAD6']",0.9999953612313965,0,0,2
423,7q11.23 copy number variation syndrome WP4932,0.8193872675139809,0.8187134502923976,0.16308645256999033,"['ATP5MC2', 'FZD9', 'HMGA1', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'ACACB', 'ATP5F1E', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'MYC', 'CFL1', 'BCL7B', 'BTK', 'EIF4H', 'GTF2IRD1', 'GAPDH', 'PRKG1', 'MAPK3']",0.9999953612313965,0,0,20
424,RANKL/RANK signaling pathway WP2018,0.8263497143534676,0.7604796927647549,0.14505177643223033,"['LYN', 'NFKBIA', 'JUN', 'VCAM1', 'SYK', 'TNFRSF11B', 'NFATC1', 'RELB', 'MAPK3', 'NFKB2']",0.9999953612313965,0,0,10
425,Hepatitis B infection WP4666,0.8278116611656239,0.835316387880231,0.15784941440888384,"['CDKN1A', 'YWHAB', 'ELK1', 'IFIH1', 'CASP10', 'MYC', 'CREB3L1', 'FADD', 'HRAS', 'MAPK3', 'JUN', 'EGR2', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'BAD', 'NFATC2', 'NFATC1', 'NFATC4', 'TGFBR2', 'CREB3', 'IRF7', 'CYCS', 'BAX', 'TLR4', 'TLR3', 'TLR2']",0.9999953612313965,0,0,28
426,Androgen receptor signaling pathway WP138,0.8307103926089726,0.7982723577235772,0.14805880683153816,"['CDKN1A', 'JUN', 'TGFB1I1', 'LIMK2', 'DSTN', 'RNF6', 'ETV5', 'FOXO1', 'EGFR', 'KAT2B', 'SUMO1', 'KAT5', 'BAG1', 'STUB1', 'FKBP4', 'RAN', 'RAD9A']",0.9999953612313965,0,0,17
427,Oxidative Stress WP408,0.8321084546122325,0.6945178626492226,0.12764716910030308,"['GPX3', 'HMOX1', 'CYBB', 'XDH', 'SOD3']",0.9999953612313965,0,0,5
428,Regulation of Actin Cytoskeleton WP51,0.8333659443080091,0.8339187811664875,0.15200873717540303,"['CHRM1', 'BRK1', 'FGF2', 'EGFR', 'ACTG1', 'PIK3R5', 'FGF7', 'FGF8', 'CFL2', 'TMSB4X', 'CFL1', 'PIP4K2A', 'RAC3', 'PIP4K2C', 'CD14', 'WASF2', 'MAPK3', 'PDGFRA', 'GSN', 'MSN', 'GNG12', 'F2', 'VAV1', 'FGF17', 'VIL1', 'DIAPH3', 'FGFR4', 'DOCK1', 'FGF10']",0.9999953612313965,0,0,29
429,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8336272828050922,0.6726286468259786,0.12239748126710635,"['BDNF', 'CGA', 'FOXO1', 'MAPK3']",0.9999953612313965,0,0,4
430,p53 transcriptional gene network WP4963,0.8357980281388997,0.7664653641207815,0.137479580343065,"['CDKN1A', 'NOTCH1', 'ADORA2B', 'GADD45A', 'CCL2', 'PMAIP1', 'BAX', 'SLC7A11', 'THBS1', 'CX3CL1', 'RPRM', 'TNFRSF10D']",0.9999953612313965,0,0,12
431,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8391690854131125,0.6390379746835443,0.11205087441149941,"['RAB27A', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,3
432,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8391690854131125,0.6390379746835443,0.11205087441149941,"['MDH2', 'IDH3B', 'SUCLG2']",0.9999953612313965,0,0,3
433,ESC Pluripotency Pathways WP3931,0.8510739763104538,0.7980671414038657,0.12869329492028353,"['PDGFRA', 'WNT10A', 'JUN', 'FZD2', 'FZD9', 'GAB1', 'LRP5', 'LIFR', 'SMAD6', 'WNT16', 'FGF2', 'ELK1', 'EGFR', 'FGF17', 'FGF7', 'FGF8', 'SELENOP', 'BMPR1B', 'FGFR4', 'HRAS', 'FGF10']",0.9999953612313965,0,0,21
434,"Cerebral organic acidurias, including diseases WP4519",0.851284332023201,0.5326417004048583,0.08576015602521496,['MDH2'],0.9999953612313965,0,0,1
435,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.851284332023201,0.5326417004048583,0.08576015602521496,['DHCR24'],0.9999953612313965,0,0,1
436,Disorders of the Krebs cycle WP4236,0.851284332023201,0.5326417004048583,0.08576015602521496,['SUCLG2'],0.9999953612313965,0,0,1
437,Glial Cell Differentiation WP2276,0.851284332023201,0.5326417004048583,0.08576015602521496,['MSN'],0.9999953612313965,0,0,1
438,Molybdenum cofactor (Moco) biosynthesis WP4507,0.851284332023201,0.5326417004048583,0.08576015602521496,['XDH'],0.9999953612313965,0,0,1
439,Pathways affected in adenoid cystic carcinoma WP3651,0.8517453719378281,0.7513769273251041,0.12057169433643901,"['CEBPA', 'NOTCH1', 'MYCBP', 'UHRF1', 'MYC', 'CHEK2', 'INSRR', 'ERBIN', 'HIST1H1E', 'IL17RD', 'FGFR4', 'HRAS']",0.9999953612313965,0,0,12
440,Osteopontin Signaling WP1434,0.8528709605870155,0.5809806493177792,0.09246133906814033,"['SPP1', 'MAPK3']",0.9999953612313965,0,0,2
441,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8538321379868303,0.7740088207449142,0.12230938798819672,"['SHC4', 'PDGFRA', 'SHC3', 'BAD', 'HGF', 'GAB1', 'FGF2', 'EGFR', 'ERBB3', 'AXL', 'MYC', 'PDGFC', 'PLCG2', 'BAX', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,16
442,p38 MAPK Signaling Pathway WP400,0.8540864315343893,0.6844981722103587,0.10796102473842574,"['RPS6KA5', 'MYC', 'DDIT3', 'HSPB1', 'ELK1', 'HRAS']",0.9999953612313965,0,0,6
443,Parkinson's disease pathway WP2371,0.8540864315343893,0.6844981722103587,0.10796102473842574,"['CASP7', 'PINK1', 'CASP6', 'SYT11', 'CYCS', 'UBE2L6']",0.9999953612313965,0,0,6
444,Target Of Rapamycin (TOR) Signaling WP1471,0.8540864315343893,0.6844981722103587,0.10796102473842574,"['IDI1', 'RRAGA', 'PRKAG2', 'DDIT4L', 'PRR5L', 'HMGCR']",0.9999953612313965,0,0,6
445,PDGF Pathway WP2526,0.854640500105804,0.6987138874809934,0.10975004101669719,"['NFKBIA', 'JUN', 'ARFIP2', 'ELK1', 'HRAS', 'VAV1', 'MAPK3']",0.9999953612313965,0,0,7
446,Regulation of Microtubule Cytoskeleton WP2038,0.856133728658242,0.7097591888466414,0.11024596500071408,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1', 'RHO', 'CDK1', 'PHLDB2', 'F2RL2']",0.9999953612313965,0,0,8
447,Angiogenesis WP1539,0.8583142504309754,0.6389465687515827,0.09762144339666243,"['PDGFRA', 'FLT1', 'TIMP2', 'FGF2']",0.9999953612313965,0,0,4
448,Gastric Cancer Network 1 WP2361,0.8583142504309754,0.6389465687515827,0.09762144339666243,"['NOTCH1', 'MCM4', 'GATD3B', 'GATD3A']",0.9999953612313965,0,0,4
449,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8583142504309754,0.6389465687515827,0.09762144339666243,"['CHEK2', 'TNFRSF10B', 'PMAIP1', 'BAX']",0.9999953612313965,0,0,4
450,Urea cycle and associated pathways WP4595,0.8583142504309754,0.6389465687515827,0.09762144339666243,"['SLC25A15', 'OAT', 'GOT1', 'MDH2']",0.9999953612313965,0,0,4
451,Ras signaling WP4223,0.8623244005223658,0.8272077590607453,0.12252911067035677,"['SHC4', 'CSF1R', 'SHC3', 'FLT1', 'PLA2G5', 'FOXO4', 'RASAL3', 'ELK1', 'ETS2', 'EGFR', 'GNG10', 'GNG3', 'PLCG2', 'RAC3', 'HRAS', 'MAPK3', 'NTRK1', 'PDGFRA', 'NGFR', 'PLA2G12B', 'PLA2G4D', 'PLA2G4E', 'BAD', 'GAB1', 'GNG12', 'GNG11', 'ZAP70', 'RASA4', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'PLA1A', 'EPHA2', 'ARF6']",0.9999953612313965,0,0,35
452,DNA damage response (only ATM dependent) WP710,0.8628042510445778,0.7886152833462988,0.11637393649391828,"['WNT10A', 'JUN', 'CDKN1A', 'TCF7L1', 'CDKN1B', 'MLKL', 'BIK', 'CDKN2A', 'BAD', 'LEF1', 'WNT16', 'PIK3R5', 'NFKB2', 'FRAT1', 'CCND3', 'BCL6', 'MYC', 'PMAIP1', 'RAC3', 'BAX', 'HRAS']",0.9999953612313965,0,0,21
453,Ebstein-Barr virus LMP1 signaling WP262,0.865755700146266,0.5990506329113924,0.08635465334900261,"['NFKBIA', 'HSP90AA1', 'NFKB2']",0.9999953612313965,0,0,3
454,16p11.2 proximal deletion syndrome WP4949,0.8694982934080229,0.7412073966642495,0.10364963289005293,"['PARP4', 'MVP', 'MSN', 'GDPD3', 'TBX6', 'SEZ6L2', 'SPN', 'TCP1', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999953612313965,0,0,13
455,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8745631606500923,0.8046558525018837,0.10784863726788621,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'EIF5A2', 'TWIST2', 'WNT8A', 'LRP5', 'CLDN2', 'FOXM1', 'DLL3', 'CLDN20', 'CDH1', 'HRAS', 'MAPK3', 'WNT10A', 'FZD2', 'GDF15', 'MMP2', 'FZD9', 'WNT9A', 'WNT16', 'TGFBR2', 'CLDN5', 'CLDN10', 'LATS2', 'CLDN9', 'COL4A6', 'COL4A5', 'STRAP']",0.9999953612313965,0,0,29
456,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.8798019408445995,0.608472307636653,0.07792002914103749,"['MYC', 'LEF1', 'LRP5', 'DKK1']",0.9999953612313965,0,0,4
457,Disorders of Folate Metabolism and Transport WP4259,0.8867364621386539,0.4565138808559861,0.054876370545765406,['ALDH1L1'],0.9999953612313965,0,0,1
458,Liver X receptor pathway WP2874,0.8867364621386539,0.4565138808559861,0.054876370545765406,['CYP3A4'],0.9999953612313965,0,0,1
459,Methylation Pathways WP704,0.8867364621386539,0.4565138808559861,0.054876370545765406,['MAT2B'],0.9999953612313965,0,0,1
460,Mitochondrial CII Assembly WP4920,0.8867364621386539,0.4565138808559861,0.054876370545765406,['SDHAF1'],0.9999953612313965,0,0,1
461,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8883867310819379,0.5637676842889054,0.06672084714266933,"['B3GALNT1', 'B3GALT1', 'B4GALNT1']",0.9999953612313965,0,0,3
462,Triacylglyceride synthesis WP325,0.8883867310819379,0.5637676842889054,0.06672084714266933,"['LPL', 'AGPAT1', 'PLPP3']",0.9999953612313965,0,0,3
463,Vitamin D in inflammatory diseases WP4482,0.8883867310819379,0.5637676842889054,0.06672084714266933,"['NFKBIA', 'VDR', 'NFATC1']",0.9999953612313965,0,0,3
464,Oxysterols derived from cholesterol WP4545,0.889984062448017,0.6387636179376742,0.07444900075735175,"['CYP39A1', 'ACOT11', 'THEM5', 'CYP3A4', 'ACOT6', 'ACOT4']",0.9999953612313965,0,0,6
465,3q29 copy number variation syndrome WP4906,0.890795752495173,0.7024150177574835,0.08122735118460628,"['CASP7', 'TM4SF19', 'JUN', 'NCBP2', 'MYC', 'DYNLT3', 'MAD2L1BP', 'SLC51A', 'DYNLL1', 'DYNLL2', 'HAMP']",0.9999953612313965,0,0,11
466,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8983983406684697,0.5807684338958079,0.06222453040726529,"['CDKN1A', 'PTH1R', 'SOX9', 'MAPK3']",0.9999953612313965,0,0,4
467,Eukaryotic Transcription Initiation WP405,0.9028264967862927,0.6386720729853016,0.06528817915330655,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999953612313965,0,0,7
468,MECP2 and Associated Rett Syndrome WP3584,0.9037226203341028,0.6965098844317317,0.07050964693429457,"['GABRR2', 'ARHGEF26', 'CEBPD', 'BCL6', 'DLX5', 'BDNF', 'SST', 'DLX6', 'GAD1', 'FGF2', 'MYT1', 'FKBP5']",0.9999953612313965,0,0,12
469,Cell Differentiation - Index expanded WP2023,0.9041281480233716,0.4915211338901544,0.04953755048657793,"['PAX7', 'KLF4']",0.9999953612313965,0,0,2
470,GPR40 Pathway WP3958,0.9041281480233716,0.4915211338901544,0.04953755048657793,"['PLCZ1', 'PLCG2']",0.9999953612313965,0,0,2
471,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9041281480233716,0.4915211338901544,0.04953755048657793,"['FRAT1', 'SOX9']",0.9999953612313965,0,0,2
472,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9041281480233716,0.4915211338901544,0.04953755048657793,"['ACLY', 'SUCLG2']",0.9999953612313965,0,0,2
473,Ectoderm Differentiation WP2858,0.9046559172294727,0.7669297352342159,0.076846826939975,"['EDA', 'ARHGDIG', 'STC1', 'PRKAG2', 'TNFRSF11B', 'JAKMIP1', 'EDA2R', 'GLI3', 'MYC', 'BOC', 'PIM1', 'CCL2', 'TBL1X', 'CTNNA2', 'TFAP2C', 'TCF7L1', 'NFATC1', 'PAX6', 'NR2F2', 'PTPN13', 'ZFHX4', 'VAX2', 'PPFIBP2', 'MAFB', 'LY6E']",0.9999953612313965,0,0,25
474,Phosphoinositides metabolism WP4971,0.9049204767369337,0.6181093031048489,0.06175419415151002,"['PIP4P1', 'PLCZ1', 'INPP5D', 'PLCG2', 'PIP4K2A', 'PIP4K2C']",0.9999953612313965,0,0,6
475,Kallmann's Syndrome WP5074,0.9075376757973816,0.5324050632911392,0.05165404448353087,"['PROKR2', 'FGF8', 'CHD7']",0.9999953612313965,0,0,3
476,Purine metabolism and related disorders WP4224,0.9075376757973816,0.5324050632911392,0.05165404448353087,"['PRPS1', 'XDH', 'APRT']",0.9999953612313965,0,0,3
477,BDNF-TrkB Signaling WP3676,0.9085462454221984,0.5914387031408308,0.05672458402373617,"['ARC', 'TRPC6', 'BDNF', 'GAB1', 'HRAS']",0.9999953612313965,0,0,5
478,ATR Signaling WP3875,0.9137387254540882,0.399418016194332,0.0360317415912101,['RAD9A'],0.9999953612313965,0,0,1
479,Biotin Metabolism (including IEMs) WP5031,0.9137387254540882,0.399418016194332,0.0360317415912101,['ACACB'],0.9999953612313965,0,0,1
480,"Degradation pathway of sphingolipids, including diseases WP4153",0.9137387254540882,0.399418016194332,0.0360317415912101,['NEU1'],0.9999953612313965,0,0,1
481,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.9137387254540882,0.399418016194332,0.0360317415912101,['TIFA'],0.9999953612313965,0,0,1
482,NLR Proteins WP288,0.9137387254540882,0.399418016194332,0.0360317415912101,['ERBIN'],0.9999953612313965,0,0,1
483,Urea cycle and related diseases WP4571,0.9137387254540882,0.399418016194332,0.0360317415912101,['SLC25A15'],0.9999953612313965,0,0,1
484,Intraflagellar transport proteins binding to dynein WP4532,0.9144082161952319,0.5554735926541667,0.04970276677617811,"['IFT140', 'DYNLT3', 'DYNLL1', 'DYNLL2']",0.9999953612313965,0,0,4
485,ATM Signaling Network in Development and Disease  WP3878,0.9155220636959165,0.6208819057273188,0.05479954301737173,"['DCLRE1C', 'KAT5', 'CDK5', 'CHEK2', 'CDK1', 'HSPB1', 'CDK5R1']",0.9999953612313965,0,0,7
486,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9180724294934647,0.5987458829490753,0.051180194684535434,"['PRKCH', 'STAR', 'CYP11A1', 'HSD3B1', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,6
487,MAPK Cascade WP422,0.9220727479367845,0.5702706614560717,0.04626671812262524,"['JUN', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.9999953612313965,0,0,5
488,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9229758312309652,0.4563763242578732,0.03657958003423019,"['MKNK2', 'MAPK3']",0.9999953612313965,0,0,2
489,Glycosaminoglycan degradation WP4815,0.9229758312309652,0.4563763242578732,0.03657958003423019,"['HPSE2', 'IDS']",0.9999953612313965,0,0,2
490,NAD+ metabolism WP3644,0.9229758312309652,0.4563763242578732,0.03657958003423019,"['NRK', 'CD38']",0.9999953612313965,0,0,2
491,1q21.1 copy number variation syndrome WP4905,0.9236580835901589,0.5043437708194537,0.04005161085461589,"['GJA1', 'PRKAG2', 'TJP2']",0.9999953612313965,0,0,3
492,Fatty Acid Biosynthesis WP357,0.9236580835901589,0.5043437708194537,0.04005161085461589,"['ACLY', 'ECHDC3', 'ACACB']",0.9999953612313965,0,0,3
493,Hippo-Yap signaling pathway WP4537,0.9236580835901589,0.5043437708194537,0.04005161085461589,"['LATS2', 'TEAD2', 'TEAD3']",0.9999953612313965,0,0,3
494,NAD+ biosynthetic pathways WP3645,0.9236580835901589,0.5043437708194537,0.04005161085461589,"['PARP4', 'CD38', 'ACMSD']",0.9999953612313965,0,0,3
495,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9236580835901589,0.5043437708194537,0.04005161085461589,"['GNA14', 'CA8', 'RYR3']",0.9999953612313965,0,0,3
496,Prolactin Signaling Pathway WP2037,0.9239413492971361,0.6801822418240826,0.05380696176277903,"['JUN', 'CISH', 'ELK1', 'PRLR', 'VAV1', 'NFKBIA', 'ZAP70', 'SOCS3', 'MYC', 'PTPN6', 'HRAS', 'YWHAG', 'MAPK3']",0.9999953612313965,0,0,13
497,Nucleotide Excision Repair WP4753,0.9267576599340017,0.6040533691319298,0.04594621507964032,"['POLE4', 'POLD4', 'CETN2', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999953612313965,0,0,7
498,16p11.2 distal deletion syndrome WP4950,0.9281247949005245,0.5322866548493289,0.0397027708029149,"['C3', 'PLN', 'SLN', 'NFATC2']",0.9999953612313965,0,0,4
499,Head and Neck Squamous Cell Carcinoma WP4674,0.931921235886352,0.6603260156270507,0.046557592331644845,"['NOTCH2', 'CDKN1A', 'NOTCH1', 'TERT', 'CDKN2A', 'GAB1', 'FADD', 'HRAS', 'EGFR', 'TGFBR2', 'PIK3R5', 'NFKB2']",0.9999953612313965,0,0,12
500,Amino Acid metabolism WP3925,0.932573613552202,0.6769138452306769,0.047253452346789224,"['AOC3', 'TPH1', 'OAT', 'GOT1', 'MDH2', 'ODC1', 'ACLY', 'TPO', 'LDHA', 'PKM', 'ALDH1A1', 'PDK4', 'ACSS1', 'HIBCH']",0.9999953612313965,0,0,14
501,DNA IR-double strand breaks and cellular response via ATM WP3959,0.933194686171539,0.624559044007408,0.04318290732836441,"['YAP1', 'DCLRE1C', 'RAD51', 'KAT5', 'CDK5', 'CDKN2A', 'CHEK2', 'BAX', 'RAD9A']",0.9999953612313965,0,0,9
502,IL-1 signaling pathway WP195,0.933194686171539,0.624559044007408,0.04318290732836441,"['NFKBIA', 'JUN', 'IL1R1', 'IL1B', 'TOLLIP', 'PELI2', 'CCL2', 'IRAK3', 'MAPK3']",0.9999953612313965,0,0,9
503,PPAR signaling pathway WP3942,0.933194686171539,0.624559044007408,0.04318290732836441,"['FABP6', 'FABP7', 'CYP4A11', 'UCP1', 'APOA1', 'LPL', 'ACSBG1', 'ANGPTL4', 'PPARA']",0.9999953612313965,0,0,9
504,Wnt signaling in kidney disease WP4150,0.9337944844572789,0.5505624847150893,0.037712926246687144,"['WNT10A', 'FZD2', 'LRP5', 'FZD9', 'WNT16']",0.9999953612313965,0,0,5
505,Autosomal recessive Osteopetrosis pathways WP4788,0.9343047195612808,0.3550101214574899,0.02412387560281202,['TCIRG1'],0.9999953612313965,0,0,1
506,Dopamine metabolism WP2436,0.9343047195612808,0.3550101214574899,0.02412387560281202,['TYR'],0.9999953612313965,0,0,1
507,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9343047195612808,0.3550101214574899,0.02412387560281202,['MAFK'],0.9999953612313965,0,0,1
508,Non-homologous end joining WP438,0.9343047195612808,0.3550101214574899,0.02412387560281202,['DCLRE1C'],0.9999953612313965,0,0,1
509,TCA cycle in senescence WP5050,0.9343047195612808,0.3550101214574899,0.02412387560281202,['GOT1'],0.9999953612313965,0,0,1
510,Valproic acid pathway WP3871,0.9343047195612808,0.3550101214574899,0.02412387560281202,['CYP2A6'],0.9999953612313965,0,0,1
511,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9366644793158049,0.5881105449889295,0.03848015563239041,"['ADCY10', 'ADCY9', 'CFL1', 'ADCY4', 'BANF1', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,7
512,Trans-sulfuration and one-carbon metabolism WP2525,0.9371626479181027,0.4790886075949367,0.03109209756167808,"['AHCY', 'DNMT3A', 'MAT2B']",0.9999953612313965,0,0,3
513,Canonical and non-canonical TGF-B signaling WP3874,0.9382871754367532,0.4259174892432296,0.027130611700259606,"['LOXL1', 'TGFBR2']",0.9999953612313965,0,0,2
514,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.9382871754367532,0.4259174892432296,0.027130611700259606,"['JUN', 'MAPK3']",0.9999953612313965,0,0,2
515,Non-small cell lung cancer WP4255,0.9395960951842894,0.6490824405747487,0.04044119961490011,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PLCG2', 'CYCS', 'BAX', 'HRAS', 'FHIT', 'EGFR', 'MAPK3']",0.9999953612313965,0,0,12
516,PDGFR-beta pathway WP3972,0.9398241221910906,0.5109546720688782,0.03171113725030076,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,4
517,Sphingolipid pathway WP1422,0.9398241221910906,0.5109546720688782,0.03171113725030076,"['CERS4', 'ACER1', 'SPTLC3', 'SERINC1']",0.9999953612313965,0,0,4
518,Cardiac Hypertrophic Response WP2795,0.9431356869924752,0.5938868747605153,0.03476917719381485,"['NPPA', 'NFATC2', 'PRKD1', 'CALM1', 'FGF2', 'CALM2', 'PRKG1', 'MAPK3']",0.9999953612313965,0,0,8
519,Glioblastoma signaling pathways WP2261,0.9462837770224675,0.6569000791481863,0.03626927902852282,"['PDGFRA', 'CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2A', 'GAB1', 'FOXO4', 'FOXO1', 'EGFR', 'ERBB3', 'CDK2', 'PLCG2', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,14
520,MTHFR deficiency WP4288,0.9484266501516813,0.45623869801084993,0.024158215487592657,"['DNMT3A', 'EHMT1', 'CYCS']",0.9999953612313965,0,0,3
521,ErbB signaling pathway WP673,0.9521903235313524,0.6555201513876038,0.03211415804071711,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'SHC3', 'BAD', 'GAB1', 'ELK1', 'FOXO1', 'EGFR', 'ERBB3', 'MYC', 'PLCG2', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,15
522,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9573410454320591,0.5674017743979721,0.02473621041314292,"['IFIH1', 'NFKBIA', 'RNF125', 'TKFC', 'CASP10', 'IRF7', 'PIN1', 'FADD']",0.9999953612313965,0,0,8
523,EPO Receptor Signaling WP581,0.957784511832223,0.4354660529344074,0.01878272288033499,"['PTPRC', 'CISH', 'MAPK3']",0.9999953612313965,0,0,3
524,Glycosylation and related congenital defects WP4521,0.957784511832223,0.4354660529344074,0.01878272288033499,"['DPM3', 'DOLK', 'MGAT2']",0.9999953612313965,0,0,3
525,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.957952960841116,0.7084288260758849,0.03043169628552716,"['SHC4', 'RAB3A', 'SHC3', 'NCF1', 'ELK1', 'ACACB', 'RPS6KA5', 'CFL1', 'IGF2BP1', 'SPP1', 'HRAS', 'MAPK3', 'NSF', 'VAV3', 'NTRK1', 'NGFR', 'EGR1', 'JUN', 'EGR2', 'BDNF', 'BAD', 'NFATC4', 'NFKBIA', 'CDK5', 'ALPL', 'CDK5R1']",0.9999953612313965,0,0,26
526,TGF-beta Signaling Pathway WP366,0.9599475126307941,0.6917998943780306,0.02827847623610299,"['KLF10', 'YAP1', 'JUN', 'CDKN1A', 'CITED1', 'ITGB4', 'TGFB1I1', 'LIMK2', 'TNC', 'THBS1', 'TGFBR2', 'TGFBR3', 'CCNB2', 'DAB2', 'COL1A2', 'PARD6A', 'TERT', 'SUMO1', 'MYC', 'CDK1', 'STRAP', 'FOSB', 'SKP1']",0.9999953612313965,0,0,23
527,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.9606675315782894,0.3757499962779341,0.015077679056271238,"['LDHA', 'ACACB']",0.9999953612313965,0,0,2
528,SARS coronavirus and innate immunity WP4912,0.9606675315782894,0.3757499962779341,0.015077679056271238,"['IFIH1', 'TLR3']",0.9999953612313965,0,0,2
529,Kit receptor signaling pathway WP304,0.961405218160686,0.5744117647058824,0.022608442597296153,"['LYN', 'BAD', 'INPP5D', 'BTK', 'PTPN6', 'HRAS', 'VAV1', 'MAPK3', 'TBX2']",0.9999953612313965,0,0,9
530,Proteasome Degradation WP183,0.961405218160686,0.5744117647058824,0.022608442597296153,"['PSMD8', 'PSMB6', 'PSMD7', 'H2AFZ', 'PSMD2', 'NEDD4', 'PSMB10', 'HLA-E', 'PSMB9']",0.9999953612313965,0,0,9
531,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.961897839506934,0.2904168200220832,0.01128183088922184,['NFKBIA'],0.9999953612313965,0,0,1
532,G Protein Signaling Pathways WP35,0.9620766895721243,0.6379380396140173,0.024663394383809777,"['GNAZ', 'PRKCH', 'ADCY4', 'AKAP5', 'GNG12', 'GNG11', 'GNA14', 'GNG10', 'GNG3', 'ADCY9', 'PRKAR1A', 'PRKD1', 'CALM1', 'HRAS', 'CALM2']",0.9999953612313965,0,0,15
533,MAPK Signaling Pathway WP382,0.9644594974274878,0.7542827129235576,0.02729556106114311,"['HSPB1', 'ELK1', 'FGF2', 'EGFR', 'RELB', 'FGF7', 'RPS6KA5', 'FGF8', 'MYC', 'STMN1', 'MKNK2', 'RAC3', 'MAP3K8', 'CD14', 'CACNG1', 'HRAS', 'CACNG4', 'CACNG5', 'MAPK3', 'DUSP4', 'NTRK1', 'HSPA8', 'JUN', 'DUSP2', 'DUSP3', 'PLA2G4D', 'IL1R1', 'GADD45A', 'BDNF', 'PLA2G4E', 'IL1R2', 'NFATC1', 'GNG12', 'DUSP6', 'NFKB2', 'TGFBR2', 'FGF17', 'NR4A1', 'DDIT3', 'IL1B', 'PTPN7', 'FGFR4', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999953612313965,0,0,45
534,Wnt signaling pathway and pluripotency WP399,0.9661249033328193,0.6378460756921513,0.021981549441126097,"['WNT10A', 'JUN', 'TCF7L1', 'PRKCH', 'FZD2', 'LEF1', 'FZD9', 'LRP5', 'PPM1J', 'WNT16', 'NKD1', 'FRAT1', 'CCND3', 'MYC', 'PRKD1', 'CD44']",0.9999953612313965,0,0,16
535,One-carbon metabolism and related pathways WP3940,0.9682850503138256,0.5039670369234462,0.016242233482055658,"['DMGDH', 'GPX4', 'GPX3', 'GAD1', 'DNMT3A', 'SOD3']",0.9999953612313965,0,0,6
536,Wnt Signaling Pathway WP363,0.9704587549234652,0.5195193248388124,0.015578501848709578,"['GSK3A', 'FRAT1', 'GJA1', 'MYC', 'LEF1', 'LRP5', 'NFATC2']",0.9999953612313965,0,0,7
537,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.9709833293540646,0.26619433198380565,0.007838352808431237,['GPRC5C'],0.9999953612313965,0,0,1
538,Disruption of postsynaptic signaling by CNV WP4875,0.9712156745628036,0.440338453209455,0.01286084165725403,"['ARC', 'YWHAG', 'MAPK3', 'SHANK1']",0.9999953612313965,0,0,4
539,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9716815489390591,0.5888860695255012,0.01691702007198216,"['EDN1', 'FZD2', 'CISH', 'NPPA', 'LRP5', 'CALM1', 'FGF2', 'CALM2', 'PRKG1', 'AGT', 'MAPK3', 'NFATC4']",0.9999953612313965,0,0,12
540,Integrated breast cancer pathway WP1984,0.9740420416529865,0.6791235122961256,0.017861500063696897,"['GSK3A', 'ODC1', 'PHB', 'HMGCR', 'JAKMIP1', 'TFPI', 'FOXO1', 'EGFR', 'CDH1', 'MYC', 'CHEK2', 'RHO', 'FADD', 'BARD1', 'PLK3', 'JUN', 'GADD45A', 'BAD', 'SMAD6', 'MYT1', 'FOSL2', 'TGFBR2', 'RAD51', 'CDK2', 'BAX', 'FAU']",0.9999953612313965,0,0,26
541,Common Pathways Underlying Drug Addiction WP2636,0.9764297723800203,0.45596323635837316,0.010875839812476407,"['DRD2', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3']",0.9999953612313965,0,0,5
542,MET in type 1 papillary renal cell carcinoma WP4205,0.9766027153353914,0.5209177207004475,0.012332907776116897,"['CDKN1A', 'JUN', 'BAD', 'HGF', 'RPL11', 'GAB1', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,8
543,Autophagy WP4923,0.9771761774044805,0.38311898734177213,0.008845573133909844,"['ATG101', 'ATG9A', 'PRKAG2']",0.9999953612313965,0,0,3
544,Resistin as a regulator of inflammation WP4481,0.9771761774044805,0.38311898734177213,0.008845573133909844,"['NFKBIA', 'PLCG2', 'MAPK3']",0.9999953612313965,0,0,3
545,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9773167992483437,0.4786926779832784,0.010983326972919668,"['PPP1R15A', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.9999953612313965,0,0,6
546,Histone Modifications WP2369,0.9773167992483437,0.4786926779832784,0.010983326972919668,"['SET', 'H3F3B', 'SUV39H1', 'EHMT1', 'SMYD1', 'HIST1H3E']",0.9999953612313965,0,0,6
547,IL-9 signaling pathway WP22,0.9779026660406335,0.24569838056680163,0.005490164066812238,['MAPK3'],0.9999953612313965,0,0,1
548,Omega-3/Omega-6 FA synthesis WP4723,0.9779026660406335,0.24569838056680163,0.005490164066812238,['PLA2G5'],0.9999953612313965,0,0,1
549,Riboflavin and CoQ disorders WP5037,0.9779026660406335,0.24569838056680163,0.005490164066812238,['RFK'],0.9999953612313965,0,0,1
550,Immune response to tuberculosis WP4197,0.9802844035371678,0.3193115666919767,0.006358304896190902,"['OAS1', 'IFIT3']",0.9999953612313965,0,0,2
551,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9803720644182591,0.41186417141130055,0.008164433634763683,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9']",0.9999953612313965,0,0,4
552,Male infertility WP4673,0.981100562910626,0.6088968438841692,0.011617943010459531,"['MMP2', 'PON2', 'HMGA1', 'PEX10', 'TEX15', 'THBS1', 'SOD3', 'ETV5', 'CYP26B1', 'SPATA17', 'FOLH1', 'TCN2', 'MSH4', 'MSH5', 'EPSTI1', 'HLA-DRA', 'SOX5']",0.9999953612313965,0,0,17
553,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9814318807149148,0.5219850636179236,0.009783394272158612,"['ACLY', 'IDI1', 'GSK3A', 'RBP4', 'HMGCS1', 'PRKAG2', 'LPL', 'HMGCR', 'ACSS1']",0.9999953612313965,0,0,9
554,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.983595423867125,0.4312481174183302,0.007133111703273266,"['FA2H', 'MAP1LC3A', 'ATG101', 'CP', 'FTL']",0.9999953612313965,0,0,5
555,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9839096462917811,0.4558254008469362,0.007394039103794433,"['ARC', 'GRIN3B', 'BDNF', 'PRKAG2', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,6
556,Estrogen signaling pathway WP712,0.9843911819315145,0.30408214918465487,0.004783795532230697,"['JUN', 'ELK1']",0.9999953612313965,0,0,2
557,Sphingolipid Metabolism (general overview) WP4725,0.9843911819315145,0.30408214918465487,0.004783795532230697,"['CERS4', 'PLPP3']",0.9999953612313965,0,0,2
558,Sphingolipid Metabolism (integrated pathway) WP4726,0.9876606315886921,0.2902372241779987,0.003603623261631716,"['CERS4', 'PLPP3']",0.9999953612313965,0,0,2
559,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9886716456076088,0.40906788247213777,0.004660514045860849,"['ABCA1', 'IDI1', 'HMGCS1', 'DHCR24', 'HMGCR']",0.9999953612313965,0,0,5
560,AMP-activated protein kinase (AMPK) signaling WP1403,0.9894229027071582,0.4724968314321927,0.005024263106642313,"['GYS2', 'GYS1', 'CDKN1A', 'LEP', 'LEPR', 'PRKAG2', 'HMGCR', 'ACACB']",0.9999953612313965,0,0,8
561,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9902412786590024,0.19958248987854252,0.001957235570520579,['ACSF2'],0.9999953612313965,0,0,1
562,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9906118536067638,0.39880952380952384,0.0037617679665316794,"['EIF4A2', 'RPS6KA5', 'PIM1', 'PIM2', 'MAPK3']",0.9999953612313965,0,0,5
563,Pancreatic adenocarcinoma pathway WP4263,0.9906243427398974,0.5240169208148965,0.004936179340134473,"['CDKN1A', 'RAD51', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'DUSP6', 'EGFR', 'TGFBR2', 'MAPK3']",0.9999953612313965,0,0,12
564,Interferon type I signaling pathways WP585,0.992082881980657,0.4160562232185149,0.003307074815598605,"['ZAP70', 'SOCS3', 'RPS6KA5', 'PTPRC', 'PTPN6', 'VAV1']",0.9999953612313965,0,0,6
565,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9925685324871009,0.18782745891879019,0.0014010460450717868,['MAP1LC3A'],0.9999953612313965,0,0,1
566,Nanoparticle-mediated activation of receptor signaling WP2643,0.9939509487450983,0.255348013161225,0.001549303867261849,"['HRAS', 'EGFR']",0.9999953612313965,0,0,2
567,EGF/EGFR signaling pathway WP437,0.9942565346207028,0.602897611553416,0.003472703810072922,"['NDUFA13', 'NEDD8', 'FOXO4', 'ELK1', 'FOXO1', 'EGFR', 'EPS8', 'GJA1', 'RPS6KA5', 'INPP5D', 'CFL1', 'STMN1', 'HRAS', 'AP2M1', 'VAV3', 'JUN', 'CAV2', 'LIMK2', 'GAB1', 'EPN1', 'VAV1', 'PLSCR1', 'NEDD4', 'FOSB', 'ARF6']",0.9999953612313965,0,0,25
568,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9943407490888018,0.17737854251012145,0.0010066809026226015,['DNMT3A'],0.9999953612313965,0,0,1
569,DNA IR-damage and cellular response via ATR WP4016,0.9957141964431447,0.4619082799457487,0.0019839025005661333,"['BARD1', 'SEM1', 'FEN1', 'RAD51', 'BCL6', 'CHEK2', 'CDK2', 'CDK1', 'FOXM1', 'RAD9A']",0.9999953612313965,0,0,10
570,Thermogenesis WP4321,0.9961040024604899,0.5067968335295068,0.001978335518902247,"['KLB', 'UCP1', 'ADCY4', 'PRKAG2', 'ACTG1', 'ADCY10', 'CREB3', 'ADCY9', 'CREB3L1', 'PRDM16', 'ZNF516', 'DPF3', 'HRAS', 'PRKG1']",0.9999953612313965,0,0,14
571,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9962601367942252,0.2363958491521134,0.0008857454559760877,"['ACTA2', 'BAX']",0.9999953612313965,0,0,2
572,Glycerolipids and Glycerophospholipids WP4722,0.9967179017982817,0.1596153846153846,0.0005247349544570006,['CDIPT'],0.9999953612313965,0,0,1
573,Nanoparticle triggered autophagic cell death WP2509,0.9975003964139086,0.1520026026604974,0.00038042190100090586,['MAP1LC3A'],0.9999953612313965,0,0,1
574,Energy Metabolism WP1541,0.9978967758158347,0.30372969648735665,0.0006394843685770159,"['UCP3', 'PRKAG2', 'PPARA', 'FOXO1']",0.9999953612313965,0,0,4
575,Ciliopathies WP4803,0.9981798845233842,0.5724605196128375,0.0010428936330921061,"['DNAH6', 'CCDC28B', 'GLI3', 'GLI2', 'ZIC2', 'SUFU', 'HYDIN', 'BBS9', 'NEK2', 'ZNF423', 'EVC2', 'DNAH11', 'RSPH4A', 'DNAAF3', 'IFT140', 'CCDC114', 'DCDC2', 'CFAP410', 'RP1L1', 'TMEM17', 'EVC', 'SMO', 'MAK', 'CCDC65', 'CCNQ', 'CCDC151', 'CCNO']",0.9999953612313965,0,0,27
576,Fatty acid beta-oxidation WP143,0.9981943662145176,0.21270564414072388,0.0003844156589113416,"['TPI1', 'LPL']",0.9999953612313965,0,0,2
577,Joubert Syndrome WP4656,0.9986579068721809,0.38621961055421133,0.0005186908287605251,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'PDE6A', 'ARR3', 'ZNF423']",0.9999953612313965,0,0,8
578,Splicing factor NOVA regulated synaptic proteins WP4148,0.9986710415811537,0.2517921385742838,0.0003348438284342674,"['CAV2', 'STXBP2', 'NCDN']",0.9999953612313965,0,0,3
579,Ciliary landscape WP4352,0.9987194987485232,0.5891911258885577,0.0007549434302847635,"['YAP1', 'DOCK5', 'SSNA1', 'USH1C', 'COPS7A', 'MYL6B', 'PSMD8', 'PSMD7', 'EXOSC4', 'ARHGDIA', 'CDH23', 'NEFL', 'BBS9', 'STOM', 'NEFM', 'DCAF11', 'TFAP2C', 'NDUFA5', 'IFT140', 'WHRN', 'DYNLT3', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'MKLN1', 'GID8', 'MCM4', 'EFHC2', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.9999953612313965,0,0,33
580,Signal Transduction of S1P Receptor WP26,0.9988953195746966,0.13297064777327935,0.00014697126482897258,['MAPK3'],0.9999953612313965,0,0,1
581,Interleukin-11 Signaling Pathway WP2332,0.9991571290205098,0.23916455696202532,0.00020166986716958074,"['SOCS3', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,3
582,Glycerophospholipid Biosynthetic Pathway WP2533,0.9995110135787492,0.11816801619433198,5.779668739475979e-05,['CDIPT'],0.9999953612313965,0,0,1
583,Insulin Signaling WP481,0.9996300766267271,0.49088175453294236,0.00018162222974042448,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'SHC3', 'STXBP2', 'GAB1', 'ELK1', 'FOXO1', 'GYS2', 'SOCS3', 'GYS1', 'RPS6KA5', 'RHOJ', 'MAP3K8', 'HRAS', 'PFKM', 'ARF6', 'MAPK3']",0.9999953612313965,0,0,21
584,Rett syndrome causing genes WP4312,0.9997329851838836,0.21250632911392406,5.674991526322902e-05,"['CECR2', 'TBL1X', 'GABRD']",0.9999953612313965,0,0,3
585,Fragile X Syndrome  WP4549,0.9998500440436497,0.39758883248730964,5.962528430482174e-05,"['GABRA1', 'DUSP3', 'BDNF', 'CDKN2A', 'GAD1', 'GAB1', 'AKAP5', 'ARC', 'PRKAR1A', 'CLTCL1', 'GABRD', 'AP2M1', 'SHANK1']",0.9999953612313965,0,0,13
586,DNA Repair Pathways Full Network WP4946,0.9998922440219038,0.3900249018293267,4.202977929915389e-05,"['FEN1', 'DCLRE1C', 'CENPX', 'CETN2', 'POLE4', 'POLD4', 'NEIL2', 'RAD51', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.9999953612313965,0,0,13
587,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999522943669169,0.37230758677459186,1.776159279610427e-05,"['GSK3A', 'SHC3', 'LPL', 'PRKAG2', 'CYP3A4', 'FOXO1', 'SLCO1C1', 'GYS1', 'RPS6KA5', 'TRIP10', 'MAP3K8', 'HRAS', 'MAPK3']",0.9999953612313965,0,0,13
588,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999910844843346,0.26770195450603695,2.3867116084542775e-06,"['EVC2', 'TMEM17', 'EVC', 'IFT140', 'CDK20', 'BBS9', 'TULP3', 'DYNLL1']",0.9999953612313965,0,0,8
589,mRNA Processing WP411,0.9999953612313965,0.2441683569979716,1.13264313543732e-06,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.9999953612313965,0,0,9
